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Abstract 
 
 
In tissue engineering, suspension culture techniques, aimed to guarantee a homogeneous 
three dimensional culture environment with enhanced mass transfer, have demonstrated 
their potentiality with respect to the traditional two-dimensional cell culture methods: they 
are currently used for low cost scalable cell expansion and long-term cell viability 
maintenance, for facilitating multicellular aggregate formation, for guiding differentiation 
of stem cells, and for the production of native-like three dimensional engineered tissues. 
However, the suspension devices currently adopted present some limitations, as the 
generation of non-physiological shear stresses and the expensive realization cost . With the 
aim to provide researchers with a yielding, versatile tool, we have developed an innovative 
low-cost perfusion bioreactor for culturing cells in suspension and low-shear conditions, 
without using electromechanical rotating systems. The peculiar geometric features of the 
culture chamber, designed with the support of a dedicated computational fluid dynamic 
study, allow the formation of buoyant vortices that guarantee the suspension condition 
within the culture chamber with low shear-stress values. In-house behavior/operating tests 
confirmed the suitability and the performances of the bioreactor, demonstrating the 
fittingness of the chamber isolation, and the establishment of suspension conditions with a 
homogeneous distribution of the samples within the culture chamber. Preliminary cellular 
tests assessed the suitability of the bioreactor in ensuring sterility and cell viability 
maintenance. This bioreactor is a compact system that easily fits into a standard cell 
incubator, representing a highly isolated dynamic cell culture setting, moreover it is 
characterized by a high versatility, since a wide range of flow patterns can be accomplished, 
permitting the adjustment of the dynamic culture parameters both to the types of cultured 
cells and to their developmental phase. In conclusion, the innovative developed bioreactor 
can be used as 1) model system, both for testing cytocompatibility and durability of cell 
microcarriers (e.g. hydrogel microspheres) and for investigating the influence of suspension 
condition on cells, with or without microcarriers, and as 2) 
expansion/aggregation/differentiation system, for in vitro three-dimensional cell culture. 
 
Keywords: tissue engineering, bioreactor design, suspension condition, oxygenation, 
shear stress. 
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1. Introduction 
 
Recently, suspension culture techniques, with or without cell microcarriers, have 
demonstrated their potentiality for low cost scalable cell expansion and long-term cell 
viability maintenance (Amit et al., 2010; Zweigerdt et al., 2011; Consolo et al., 2012; Olmer et 
al., 2012), for facilitating multicellular aggregate formation (Sen et al., 2001; Cameron et al., 
2006; Wang et al., 2006), for guiding differentiation of stem cells (SCs) (Siti-Ismail et al., 
2012), for preventing the dedifferentiation process that occurs under traditional two-
dimensional (2D) cell culture conditions, maintaining specialized features of cells 
(Hammond and Hammond, 2001), and for the production of native-like three dimensional 
(3D) engineered tissues (Hwang et al., 2009; Yu et al., 2011).  
To date, suspension condition is obtained with roller-bottles, stirred or rotating 
bioreactors. 
The roller-bottle system, involved in advanced physiological and biochemical 
research on scale-up of anchorage-dependent mammalian cells and microorganisms, 
consists of cylindrical vessels that revolve slowly (between 5 and 60 revolutions per hour) 
which bathe the cells that are attached to the inner surface with medium. This system 
represents a very economical means for cultivating large quantities of anchorage-
dependent cells using essentially the same culture techniques as with traditional cell culture 
flasks but with considerably less labor. In addition, besides providing larger surface areas 
for cell growth, culturing cells with roller-bottles has two advantages over static monolayer 
culture: firstly, the gentle agitation prevents gradients from forming within the medium 
that may adversely affect growth; secondly, cells spend most of their time covered by only 
a thin layer of medium, thus allowing for higher gas exchange 
(http://www.sigmaaldrich.com/labware/labware-products.html?TablePage=9577881). Some 
research groups have demonstrated that anchorage-dependent cells cultured within roller- 
bottles present higher proliferation rate (Polatnick and Bachrach, 1972; Yu et al., 2009; 
Andrade-Zaldívar et al., 2011), generating cell in large-scale, cutting down on the amount of 
laboratory manipulations, and saving both time and labor costs. Despite all these 
advantages, roller-bottles present some technological limitations and drawbacks. They 
impose severe mechanical stresses on the cultured constructs, with a mixing of fluid not 
well distributed especially in the axial direction. Moreover, due to the incomplete filling of 
the vessel, the air in the headspace creates turbulence and secondary bubble formation in 
the culture medium, which are both potent sources of extra shear and turbulence (Unger et 
al., 2000). 
More recently, stirred bioreactors (or spinner flasks) were developed. Within these 
devices, a magnetic stirrer allows the mixing of the culture medium while the cultured 
constructs are fixed with respect to the moving fluid. Flow across the surface of the 
constructs results in eddies, turbulent instabilities consisting of clumps of fluid particles 
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that have a rotational structure superimposed on the mean linear motion of the fluid 
particles. They are associated with transitional and turbulent flow. It is via these eddies that 
fluid transport through the constructs is thought to be enhanced (Goldstein et al., 2001). 
Typically, spinner flasks are around 120 ml in volume (although much larger flasks of up to 8 
liters have been used), and are run at 50-80 rpm (Freshney, 2000). Recent finding 
demonstrated that this 3D culture systems, based on both agitator design and agitation 
rate, as well as on the establishment of critical inoculum densities, provide an efficient in 
vitro environment for SC proliferation and differentiation, and could act as SC delivery 
microspheres for autologous tissue engineering (TE) (Fok and Zandstra, 2005; Cameron et 
al., 2006; Liu and Roy, 2006; Kehoe et al., 2010; Choi et al., 2011; Lee et al., 2011). Importantly, 
the use of these bioreactors enables the expansion of SCs in the absence of feeder layers or 
matrices, which will facilitate the adaptation of good manufacturing practice (GMP) 
standards to the development of SC therapies (Krawetz et al., 2010). However, due to both 
local turbulence and the high flow rates created between the vessel walls and the magnetic 
stirrers, stirred bioreactors impose non-physiological shear stresses on cultured constructs, 
therefore potentially inducing cell damage, and interfering with SC pluripotency. Moreover, 
this inhomogeneity in the shear field could limit the reproducibility of the culture process 
and the consequent interpretation of the results. 
Starting from the need to minimize shear and turbulence in suspension cell cultures, 
NASA's Biotechnology Group developed an alternative bioreactor design, the rotating-wall 
vessel (RWV), with interesting and unique features for mammalian cell cultivation (Goodwin 
et al., 1993; Hammond and Hammond, 2001). This bioreactor exists in two different 
configurations, the High Aspect Ratio Vessel (HARV) and the Slow Turning Lateral Vessel 
(STLV) (Rodrigues et al., 2011). Both provide fluid dynamic operating principles 
characterized by 1) a permanent rotation of the culture chamber, the rotation speed of 
which is adjusted to produce a free-falling state, optimally reduced fluid shear and 
turbulence, and 3D spatial freedom; and 2) oxygenation by diffusion, excluding undissolved 
gases from the bioreactor (Wolf and Schwarz, 1991; 1992; Schwarz and Wolf, 1991; Goodwin 
et al., 1993). These technological solutions encourage a uniform growth of the tissues, and 
promote cellular interactions. Moreover, the RWV bioreactors protect fragile tissues from 
cracking because mechanical stresses are reduced, including shear stress, and the impact of 
the cells on the bioreactor walls is limited (Bilodeau and Mantovani, 2006). These 
bioreactors have been successfully used for osteogenic (Granet et al., 1998; Qiu et al., 1999; 
Turhani et al., 2005; Song et al., 2006) and cardiomyogenic (E et al., 2006) differentiation, 
and cartilage TE (Marolt et al., 2006). However, rotating bioreactors are expensive devices 
due to their complex technological solutions, and scaling up processes may be complex 
(Hammond and Hammond, 2001; Rodrigues et al., 2011). 
In order to overcome the previously presented limitations, we have developed an 
innovative multipurpose low-cost perfusion bioreactor (patented, Falvo D’urso Labate et 
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al., 2012) able to establish a biochemical and hydrodynamic environment suitable for 
maintaining specimen of different dimensions (i.e., cells, microspheres etc.) in suspension 
conditions within a 3D culture environment. The peculiar geometric features of the 
bioreactor assure the possibility for buoyant vortices to be generate within the culture 
chamber, without using electromechanical rotating systems and avoiding shear stress 
values critical for the cells, guaranteeing a suitable and homogeneous distribution of 
oxygen and nutrients. In-house behavior/operating tests confirmed the suitability and the 
performances of the bioreactor, demonstrating the fittingness of the chamber isolation, 
and the establishment of suspension conditions with a homogeneous distribution of the 
samples within the culture chamber. Preliminary cellular tests assessed the suitability of the 
bioreactor in ensuring sterility and cell viability maintenance. In conclusion, the innovative 
developed bioreactor can be used as 1) model system, both for testing cytocompatibility 
and durability of cell microcarriers (e.g. hydrogel microspheres) and for investigating the 
influence of suspension condition on cells, with or without microcarriers, and as 2) 
expansion/aggregation/differentiation system, for in vitro 3D cell culture. 
 
2. Materials and Methods 
 
2.1 Device requirements 
 
The bioreactor was designed and developed in order to guarantee a suitable biochemical 
and hydrodynamic 3D culture environment for maintaining specimen of different 
dimensions (i.e., cells, microspheres etc.) in suspension conditions with enhanced mass 
transfer and low shear stress. 
Within the bioreactor, suspension is obtained due to peculiar geometric features which 
assure the possibility for buoyant vortices to be generate, allowing the device to create 
suspension conditions, and to be employed with several constructs and for different 
applications. In order to assure full compatibility with GMP procedures, the bioreactor was 
developed for satisfying the following requirements: 
 cytocompatibility and corrosion‐resistance of all the materials in contact with culture 
medium; 
 ease of sterilization and sterility maintenance; 
 ease of use (assembly in sterile conditions under a laminar flow hood, cleaning, use for 
non‐trained staff); 
 small dimensions, suitable for positioning in a cell culture incubator; 
 no medium stagnation during exchange operations. 
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2.2 Architectural design 
 
Key constitutive elements of the bioreactor are (Figure III.1): 
 a transparent, sealable and sterile culture chamber where cells, with or without 
microcarriers, and culture medium are housed during the experiments; 
 a perfusion subsystem constituted by a medium reservoir, a peristaltic pump, and 
oxygen permeable tubes (oxygenation module), that is designed to maintain the 
suspension environment. 
 
Figure III.1. Architectural design of bioreactor constituted of: a medium reservoir; a peristaltic pump; a culture 
chamber; and oxygen permeable tubes. 
 
Pumped by a peristaltic pump the culture medium enters from the base, opens the check 
valve, and pervades the culture chamber, flowing out from the top (Figure III.2). 
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Figure III.2. Bioreactor constructive drawing. Flow direction/movement is highlighted. Configuration with check 
valve in the closed position (left). Configuration with check valve in the open position (right).  
 
During the experiment, the culture chamber, the fresh media reservoir, and a portion of the 
oxygen‐permeable tubes are positioned within the incubator. The peristaltic pump is 
positioned outside to protect it from the high humidity (95% - 37°C) that characterizes the 
internal environment of the incubator (Figure III.3). Depending on the model of incubator, 
we tested two configurations of the bioreactor within the incubator, i.e., whether it 
presents (Figure III.3 right panel) or not (Figure III.3 left panel) an exit hole. 
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Figure III.3. Bioreactor set-up within the incubator in the two possible configurations. Schematic drawing (top) 
and picture (bottom) of the bioreactor set-up within a incubator without an exit hole (left panel). Schematic 
drawing (top) and picture (bottom) of the bioreactor set-up within a incubator with an exit hole (right panel). 
The legend refers to both configurations. 
 
2.3 Bioreactor constitutive elements 
 
2.3.1 Culture chamber 
 
The bioreactor culture chamber (component 5 in Figure III.4b), where cells are cultured, has 
been designed to be a sterile and cytocompatible environment. It has been manufactured 
through material removal by a micrometrical controlled cutter from a polycarbonate (PC) 
bulk piece, a choice that guarantees biocompatibility and easier sterilization by autoclave. 
The inner dimensions are approximately 95x70x70 mm3 with a working volume of 75 ml. 
The geometric features of the bioreactor culture chamber have been designed with the 
final goal to establish the formation of buoyant vortices, and therefore the generation of 
suspension condition. Moreover, rounded edges were designed in order to avoid 
stagnation points and discontinuities, fissures, interstices, holes, which are preferable 
targets for microbial contamination. Within the culture chamber are located 1) a check valve 
for guarantying the unidirectionality of the flow (component 6 in Figure III.4b), and 2) a 
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filter, for preventing accidental outputs of cells or constructs during the recirculation of the 
culture medium (component 4 in Figure III.4b).  
Figure III.4b shows a detailed view of the bioreactor components. 
 
 
Figure III.4. Bioreactor. a) Picture of the entire device. b) CAD design of the bioreactor components: (1) thumb 
screw, (2) flow outlet, (3) lid, (4) filter, (5) culture chamber, (6) check valve, (7) membrane holder 1, (8) 
membrane, (9) bushing, (10) membrane holder 2, (11) perforated plate (collimator), (12) base, (13) flow inlet. 
 
Check valve 
 
The innovative check valve (Figure III.5) has been designed for guarantying the 
unidirectional flow of the culture medium within the circuit. The valve motion from the 
closed to the open position and vice versa is vertical and it is obtained by means of a moving 
silicone membrane. 
 
 
Figure III.5. Check valve. a) Picture of the check valve without the membrane holder 2. b) Check valve CAD 
design. 
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The flow of the culture medium within the device is achieved by production of over 
pressures in the valve chamber, with respect to the culture chamber: the medium flows 
only when the transvalvular pressure difference overcomes the cracking pressure of the 
valve. The silicone membrane, with a thickness of 2 or 3 mm depending on the rigidity 
which is desired for the system, is designed with six holes, each one of them housing a 
bushing that can be open or closed in order to modulate the proper operating transvalvular 
pressure (Figure III.6). 
 
 
Figure III.6. Picture of the silicone membrane. a) Lateral view. b) Three possible configurations; from the left: 2, 
4 or 6 open holes, respectively. c) Silicone membrane assembled with the check valve system.  
 
Filter 
 
The PolyVinyliDene Fluoride filter (PVDF - Durapore® Millipore, free passage diameter = 5 µm 
– porosity = 80%) has been designed in order to prevent accidental outputs of cells or 
constructs during the recirculation of the culture medium. In addition to the PVDF filter, the 
entire filter set-up has been designed considering also the insertion of 3 silicone washers 
and one AISI 316L stainless steel grate (Figure III.7a-f).  
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Figure III.7. Bioreactor filter set-up. a) Filter components. b) Insertion of the first silicone washer. c) Insertion 
and positioning of the PVDF filter. d) insertion of the second silicone washer. e) insertion of the AISI 316L 
stainless steel. f) Insertion of the third silicone washer. g) completed filter set-up. 
 
The first two silicone washers, positioned before and after the PVDF filter, allow to maintain 
the correct positioning of the filter, and to prevent leakage of the medium (Figure III.7b-d). 
The AISI 316L stainless steel grate, positioned after the second silicone washer, ensures 
greater rigidity of the PVFD filter, avoiding sudden breakage due to accidental air bubble 
formation or pressure increases within the culture chamber (Figure III.7e). Finally, the last 
silicone washer positioned between the grate and the lid, guarantees the tightness of the 
coupling, and allows to avoid direct contact between the AISI 316L stainless steel of the 
grate and the PC of the lid, potentially causing damages of the material (Figure III.7f). 
 
2.3.2 Perfusion subsystem 
 
The perfusion subsystem (Figure III.8) is composed of a medium reservoir, a peristaltic 
pump, quick-disconnected couplings, and oxygen-permeable tubes. 
 
Chapter III – An innovative suspension bioreactor 
113 
 
 
Figure III.8. Bioreactor perfusion subsystem set-up. 
Medium reservoir  
The role played by the reservoir is dual: it contains sterile medium for cell feeding, and it 
enhances mass transfer to provide oxygenated media (it is a free-surface reservoir) (Figure 
III.9). 
 
 
Figure III.9. Picture of the medium reservoir with the in-flow and out-flow tube. 
 
Pump 
A peristaltic pump has been chosen (Masterflex L/S® RX-07551 – 00) to assure recirculation. 
Pump features are summarized in Table III.1: 
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Table III.1. Technical features of the Masterflex L/S® RX-07551 – 00 pump. 
Flow rate values 
VAC 
rpm 
Speed control 
Operating temperature 
Drive dimensions 
motor 
0.006 - 3400 ml/min 
90/260 
0.1 - 600 
precision digital ± 0.1% 
0 - 40°C 
25.4 cm x 21.6 cm x 21.6 cm (10” x 8.5” x 8.5”) 
75 watts, 1/10 hp 
 
Couplings 
Cole-Parmer quick-disconnect couplings able to process the fluidic circulation in the system 
and to ensure unidirectionality to the flow have been chosen (Figure III.10). Coupling 
features are summarized in Table III.2. 
 
Table III.2. Technical features of the Cole-Parmer quick-disconnect couplings. 
Body material 
Seal material 
Spring and latch material 
Max vacuum 
Max temperarure 
Max pressure at 21°C 
Acetal 
Ethylene Propylene Rubber (EPR) 
316 Stainless Steel 
28” Hg 
71°C 
100 psi 
 
 
 
Figure III.10. Cole-Parmer quick-disconnected couplings. 
 
Tubing 
The oxygenation and partially the hydraulic compliance are assured by the Masterflex 
BioPharm Platinum-Cured Silicone Pump Tubing (Hose barb 1/4”, ID 6.4 mm), retaining the 
following features shown in Table III.3:  
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Table III.3. Technical features of the Masterflex BioPharm Platinum-Cured Silicone Pump Tubing. 
Material 
Operating temperature 
Methods of sterilization 
Tygon 3350 silicone, platinum-cured 
-60 to 232°C 
Ethylene oxide, gamma irradiation, or autoclave for 30 min, 15 psi 
 
Permeability properties to CO2, H2, O2 and N2 are summarized in Table III.4. 
 
Table III.4. Permeability properties of Masterflex BioPharm Platinum-Cured Silicone Pump Tubing. 
Permeability (approx) at 25°C 
 
       {
     
              
}          
 
CO2 H2 O2 N2 
20,132 6579 7961 2763 
 
In Appendix III.A, at the end of the chapter, the sizing of the perfusion subsystem with a 
detailed description of the methods and the results obtained, is reported considering two 
different cases: 1) a fixed number of cells, considering neonatal rat cardiomyocytes (CMs) 
and 2) a variable number of cells due to proliferation, modeling mesenchymal stem cells 
(MSCs). 
 
2.4 Computational fluid dynamic study 
 
Computational fluid dynamic (CFD) multiphysics simulations were performed to identify the 
optimal design and proper operating conditions that optimize mass transport, and to study 
the construct-medium interaction.  
A customized commercial software based on finite volume technique (FLUENT, 
ANSYS Inc., USA) was used. Previously, axial symmetric single phase computational 
simulations were performed to identify the optimal wall shape promoting the generation of 
buoyant vortices. The culture medium (density=1006.5 kg/m3, viscosity=0.001 kg/(m·s)) was 
simulated as Newtonian fluid. Afterwards, the 3D fluid domain within the culture chamber 
was discretized with approximately 2x106 tetrahedral cells (Figure III.11), and 3D multiphase 
simulations were performed (time step = 2 ms), considering culture medium as primary 
phase and hydrogel microspheres (density=1118 kg/m3, viscosity=0.001 kg/(m·s), 
diameter=200 μm) as secondary phase.  
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Figure III.11. Discretization of the 3D fluid domain with imposed conditions. 
 
The concomitant presence of culture medium and microspheres was modeled using the 
Eulerian–Eulerian Multiphase Model, which allows to describe mixtures of multiple 
separated yet interacting phases. As initial condition, a volume fraction (VF) of 
microspheres equal to 2% was uniformly set in the lower region of the bioreactor. The filter 
was modeled as porous medium, impermeable to the microspheres phase. CFD simulations 
were carried out varying the inlet velocity of the culture medium (laminar flow condition). 
At the wall, no slip conditions were imposed.  
 
2.5 Tests 
 
2.5.1 In-house factory tests 
 
Preliminary in house/behavior tests were conducted to investigate suitability and 
performances of each component of the bioreactor. In particular, tests 1) to understand if 
the bioreactor was able to withstand the stresses due to the passage of the fluid, 2) to 
investigate the ability to generate buoyant vortices, with the consequent establishment of 
suspension condition, and 3) to find out the proper bioreactor configuration that allows a 
homogeneous distribution of the cells or constructs within the culture chamber, were 
performed. As preliminary test, to simulate the presence of constructs within the culture 
chamber, injectable thermoreversible polyurethane (PU) microspheres (with a diameter 
equal to 500 µm after swelling) were used. 
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2.5.2 Preliminary cellular tests 
 
With the aim to verify the suitability of the device to be used in cardiac TE, a preliminary test 
of dynamic cell culture was performed by the Group of Professor Quaini, Department of 
Internal Medicine and Biomedical Sciences, Section of Internal Medicine, University of 
Parma, Italy. 
Enhanced Green Fluorescent Protein Cardiac Progenitor Cells (EGFPpos CPCs) 
isolated from adult EGFP rat hearts (for detailed procedure see Beltrami et al., 2003), were 
seeded on gelatin/gellan microspheres with an average diameter of 125÷300 or 350÷450 
µm, respectively. Gelatin/Gellan microspheres functionalized with Insuline-like Growth 
Factor 1 (IGF-1, 0.25µg/mg) with diameter less than 90 µm were also tested. Dynamic culture 
of EGFPpos CPCs alone was used as control.  
Cells were seeded on cardiac injectable microspheres at the concentration of 
105cells/100µl and statically cultured for 48 h in complete growth medium (IMDM (Sigma, 
Italy), 1% P/S (Sigma, Italy), 1% I/T/S (Sigma, Italy), 10% FBS (Sigma, Italy)) to promote cell-
microsphere adhesion. Analysis by inverted and fluorescence microscope (Leica DMI6000B) 
was performed immediately after mixing cell to microspheres to document efficiency of 
suspension. 
After 48 hours of static culture, the adhesion of the cells to the biomaterials was 
assessed employing inverted and fluorescence microscope. After visualization, the 
suspension of EGFPpos CPCs and microspheres was inserted within the culture chamber for a 
total number of cells equal to 6X105, and in detail for a cell density of 1.2 X104 cells/ml, and 
cultured for further 24 h in dynamic conditions (flow rate 5 ml/min). 
After 24h of dynamic culture cells and microspheres were rescued from the culture 
chamber, re-suspended in fresh growth medium, seeded in a “Ultra Low-Attachment” 96 
well plate (Corning, USA) to avoid adhesion and analyzed with optical and fluorescence 
microscopes to assess the conjugation between EGFPpos CPCs and microspheres. In order to 
verify if the presence of cells was limited to the culture chamber, the culture medium was 
also collected from reservoir, tubes, lid and base. Moreover, the filter was fixed with 
paraformaldehyde (PFA) 4% for 30 minutes and then stained with DAPI (4',6-diamidino-2-
phenylindole, Sigma, Italy) for 15 minutes at room temperature in order to verify the 
presence of cells on its surface. Photomicrographs of EGFPpos CPCs collected from the 
culture chamber were taken and then analyzed by a software for image analysis (Image 
Pro-plus 4.0, Media Cybernetics, Inc., USA), to quantify cell persistence, adhesion and 
distribution on cardiac injectable prototypes.  
After image analysis, EGFPpos CPC – microsphere suspension was re-seeded on 
“Normal-Attachment”96-well (Corning, USA), and cultured for 5 days in static conditions to 
verify cell survival and proliferation. 
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The quantitative analysis of cell adhesion to microspheres after 24 h of dynamic culture and 
after 5 days in static condition was performed evaluating the fractional area occupied by 
EGFPpos CPCs. Briefly, green fluorescence emission and its intensity, expressed as Integrated 
Optical Density (IOD), were computed using a software for image analysis (Image Pro-plus 
4.0, Media Cybernetics, Inc., USA).  
All images were acquired with precalibrated gain and exposure time. Aspecific 
fluorescence was carried out by merging the emission signals from different excitation 
lengths on the same microscopic field. 
 
3. Results 
 
3.1 Computational fluid dynamic study 
 
Results of CFD simulations performed for assisting the bioreactor design, for studying the 
microspheres-medium interaction, and for identifying the operating conditions that 
optimize mass transport were performed are summarized in Figure III.12. 
This figure shows contour map of microsphere VF with superimposed microsphere velocity 
vector field obtained from the 3D simulations (flow rate = 90 ml/min).  
 
 
Figure III.12. Map of microsphere VF superimposed to microsphere velocity vector field. Inset: distribution of 
microsphere VF within the culture chamber volume. The microsphere VF peak value of 63% is the packing limit 
value for the microspheres, as well indicated, but never attained. 
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A buoyant toroidal vortex develops in the lower region of the culture chamber, 
counterbalancing the gravity force acting on microspheres and maintaining them in 
suspension (no microsphere sedimentation was observed). Near to the outer wall, a smaller 
second toroidal vortex (red arrow) is generated, which could play the beneficial role of 
enhancing the mixing of floating microspheres. The maintenance of microsphere VF values 
close to the initial value (2%) indicates that detrimental microsphere/microsphere collisions 
are avoided. This result is also confirmed by the analysis of the distribution of the 
microsphere VF within the lower part of the flow chamber (i.e., where microspheres are 
present): the inset in Figure III.12 shows that (1) about the 95% of the microspheres is 
subjected to low packing levels (VF lower than 3.9%), and (2) only the 2.7% of the 
microspheres is subjected to packing greater than VF=10%. These results are a further 
demonstration that, within the bioreactor, microsphere suspension is promoted while 
sedimentation is avoided. As for possible cell damage, it was found that in the lower part of 
the culture chamber the 95% of the suspended microspheres is subjected to shear stress 
values lower than 17 mPa equal to 0,17 dyn/cm2. This finding confirms that there is no risk of 
mechanical damage to cultured cells when suspension condition is generated into the 
bioreactor (Isu et al., 2013). 
Findings from CFD simulations are in agreement with the experimental results presented in 
the following sections.  
 
3.2 Tests  
 
3.2.1 In-house factory tests 
 
Initially, to demonstrate the suitability of the device, the generation of buoyant vortices, 
and the consequent establishment of suspension condition, in house behavior/operating 
tests were performed.  
The first test was dedicated to verify the suitability of the bioreactor to withstand 
the hydrodynamic pressures developing within the culture chamber due to the perfusions 
subsystem. Therefore, proceeding step by step, the flow rate was increased of 10 ml/min at 
each step, starting from 10 ml/min and reaching the final value of 250 ml/min. With these 
tests it has been demonstrated that the bioreactor responds well to any stress imposed by 
the flow rate. Moreover, no losses have been observed, and disassembling the bioreactor 
no abnormalities in the control system of the check valve have been noticed. The test 
certificated the fittingness of chamber isolation, and the ability of the bioreactor to 
withstand even at high flow rates. 
The second test was dedicated to assess the formation of buoyant vortices and 
consequent suspension conditions within the culture chamber, finding out the proper 
bioreactor configuration that allows a homogeneous distribution of the cells or constructs 
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within the culture chamber. Findings obtained confirmed by visual inspection that, using 
the two possible configurations reported in Figure III.13, injectable thermoreversible PU 
microspheres were homogenously distributed within the culture chamber, no microsphere 
sedimentation occurs, and no microspheres reached the filter (Figure III.14).  
 
 
Figure III.13. CAD design of the bioreactor configurations that allow a homogenous distribution of samples 
within the culture chamber. Configuration with the 2mm thickness silicone membrane (top). Configuration with 
the 2mm thickness silicone membrane (bottom). 
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Figure III.14. Picture of the injectable thermoreversible PU microspheres homogenously distributed within the 
culture chamber. 
 
In detail, findings from in-house behaviour tests and CFD simulations have demonstrated 
that the maintenance of adequate suspension conditions is achieved through the 
attainment of a dynamic balance among the different forces acting simultaneously. The 
result of the balance between hydrodynamic and gravitational forces is the achievement of 
suspension for cultured cells or constructs, within a dynamic environment in which the 
shear stress values acting on the cells are lower respect to the critical values and the 
nutrient supply to the cultured cells is maximized.  
The proper combination (1) of the fluid dynamic conditions establishing at the inlet 
of the chamber with (2) the shape of the side walls of the chamber itself give rise to flow 
separation, with the consequent formation of stationary buoyant vortices and of 
hydrodynamic forces the resultant of which balances the gravitational force, thus avoiding 
the sedimentation of cultured specimen at the bottom of the culture chamber. In detail, the 
suspension condition results from a net sum of all forces present equalling zero, not from 
an absence of gravity (Klaus, 2001). Gravitational and hydrodynamic forces, including 
buoyant and drag forces which result from the operating chamber in the gravitational field, 
combine simultaneously to produce a “suspension” condition for the immersed particles. In 
this way particles experience an average near zero gravitational force, thereby leading to 
what has been described as the “simulated microgravity” condition. Furthermore, the 
buoyant vortex assures proper mixing within the chamber and hence oxygen uptake to the 
cells. 
The fluid (i.e., the culture medium) is mixed within a laminar flow environment and 
potentially damaging cell due to bead-fluid friction and bead-bead collisions is minimized in 
suspension conditions, conversely to what has been reported for dynamic bioreactors 
based on the agitation/stirring mechanism, where the onset of turbulences in the fluid flow 
typically occurs.  
This design philosophy allows to not incorporate rotating components within the 
device. 
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3.2.2 Preliminary cellular tests 
 
Preliminary cellular tests demonstrated that all the materials, that can be sterilized by 
autoclave before setting up the experiment, are highly cytocompatible and corrosion 
resistant. The set up procedure can subsequently be performed under a laminar flow hood 
in accordance with the GMP rules, maintaining the sterility of the culture chamber. Thanks 
to the limited number of components and to the bioreactor organization, the operations 
that need to be conducted under laminar flow are: (1) closure of the base; (2) priming and 
start of the peristaltic pump; (3) injection of the cells; (4) positioning of the filter; (5) 
insertion of the lid; and (6) closure of the perfusion circuit. All of them can be quickly and 
easily performed maintaining the sterility of the culture chamber and of the biological 
samples during the entire experiment. Moreover, these tests confirmed that, throughout 
the duration of the experiment, the bioreactor has proved to be a reliable, autonomous and 
safe device, able to guarantee the sterility and the viability of the cell culture. The culture 
chamber, which proved to be extremely comfortable in handling, showed no sign of 
microbial contamination; medium reservoir and permeable tube provided the necessary 
oxygen supply to cultured cells; and no cells were found on the PVDF filter or within the 
medium collected from the medium reservoir, lid, tubes, and base of the bioreactor, 
certificating the fittingness of chamber isolation. 
In detail, results from preliminary tests demonstrated initially the cell-gelatin/gellan 
microsphere conjugation (Figure III.15).  
 
 
Figure III.15. Cell-microsphere constructs before static culture. A) CPCs (black arrows) and microspheres (125 ÷ 
300 µm) in suspension. Scale bar 200 µm. B) EGFPpos CPCs (green fluorescence) and microspheres (350 ÷ 
450µm) in suspension. Scale bar 250 µm. C) EGFPpos CPCs (green fluorescence) and microspheres functionalized 
with IGF-1 (d<90) in suspension. Scale bar 50 µm. 
 
It is possible to observe a homogeneous distribution of the two components, with 
differences between the different type of microspheres. Microspheres with a diameter 
ranging from 125 to 300 µm are better separated from each other (Figure III.15A), whereas 
microspheres with a diameter ranging from 350 to 450 µm tend to aggregate (Figure 
III.15B). On the other hand, microspheres functionalized with IGF-1 (d<90) and EGFPpos CPCs, 
suspended in growth medium, are individually and equally distributed (Figure III.15C). 
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After 48 hours of static culture, cells adhered to the surface of 125÷300 µm microspheres 
mainly as clusters (Figure III.16). On the other hand, EGFPpos CPCs were conjugated to 
350÷450 µm microspheres mainly as individual cells laying the cytoplasm over microsphere 
surface (Figure III.17). 
 
 
Figure III.16. CPCs seeded on 125 ÷300 µm microspheres after 48h of culture in static condition. Black arrows 
indicate cells adhered to microspheres and asterisks indicate cell clusters; white arrows point out to single cells 
which adhered to the bottom of the dish. Scale bars: 500 µm (left) and 200 µm (right). 
 
 
Figure III.17. CPCs seeded on 350 ÷450 µm microspheres after 48h of culture in static condition. Green 
fluorescence corresponds to cells adhered to microspheres at different magnifications. Scale bars: 500 µm (left) 
and 250 µm (right). 
 
EGFPpos CPCs adhere to microspheres functionalized with IGF-1 mainly as individual cells. 
Moreover, the presence of microspheres with altered morphology, probably due to an early 
degradation process, was observed (Figure III.18). 
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Figure III.18. EGFPpos CPCs (green fluorescence) seeded on microspheres functionalized with IGF-1 after 48h of 
culture in static condition. White arrowhead indicates a single cell adhering to microsphere and asterisk 
indicates microsphere with altered shape. Scale bar 200 µm. 
 
Results after 24 hours of dynamic culture are described below. 
 
- Gelatin/gellan injectable microspheres (diameter 125÷300 µm): CPCs mostly adhered to 
smaller microspheres, covering entirely their surface. Cells also surrounded the edge of 
larger microspheres. After 24 hours of dynamic culture CPCs were organized in small 
spherical clusters, suggesting a possible role of the bioreactor in creating a 
microenvironment suitable for stemness preservation, knowing that sphere formation in 
vitro is a characteristic feature of embryonic and adult SCs (Figure III.19A). 
EGFPpos CPCs conjugated to microspheres collected from the bioreactor were then cultured 
for 5 days in static conditions and subsequently analyzed under inverted and fluorescence 
microscope. These observations confirmed that CPCs mainly adhered to smaller 
microspheres. Progenitor cells that were not conjugated to microspheres were also present 
providing evidence of their viability and proliferative ability. After 5 days of static culture, 
changes in gelatin/gellan microspheres morphology which suggest the presence of 
biodegradation were observed (Figure III.19B). 
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Figure III.19. A) EGFPpos CPCs (green fluorescence) adhered to smaller microspheres (white arrows); 
microspheres (*) and small clusters of EGFPpos CPCs (red arrows), collected from the culture chamber of the 
bioreactor after 24h of dynamic culture. Scale bar 500 μm. B) EGFPpos CPCs (green fluorescence) adhered to 
smaller microspheres (white arrows); microspheres (*) and small clusters of EGFPpos CPCs (red arrows), after 5 
days of static culture. Scale bar 1mm. 
 
- Gelatin/gellan injectable microspheres (diameter 350÷450 µm): after 24 hours of dynamic 
culture, CPCs still adhered to microspheres spreading their cytoplasm on microsphere 
surface (Figure III.20). 
 
 
Figure III.20. EGFPpos CPCs seeded on 350 ÷450 µm microspheres after 24h of dynamic culture. Green 
fluorescence shows adhering cells to microspheres at two different magnifications. Scale bars: 500 µm (left) 
and 250 µm (right). 
 
After 5 days of static culture, cell and microsphere suspension were analyzed under 
inverted and fluorescence microscope. We observed that gelatin/gellan injectable 
microspheres changed their morphology and structure. CPCs were mainly conjugated to 
microsphere and only few adhered to the culture dish (Figure III.21). 
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Figure III.21. EGFPpos CPCs seeded on 350 ÷450 µm microspheres after 5 days of static culture. Cells adhered to 
microspheres appear in green fluorescence. Scale bars: 500 µm (left) and 250 µm (right). 
 
- Gelatin/gellan microspheres fuctionalized with IGF-1 (d<90 µm): after 24 hours of dynamic 
culture, CPCs still adhered to microspheres and at time were laying on microsphere surface. 
Occasionally, CPCs were found at the interface between two or more microspheres 
resembling connecting elements (Figure III.22). 
 
 
Figure III.22. EGFPpos CPCs (green fluorescence) seeded on microspheres functionalized with IGF-1 d<90 µm 
after 24h of dynamic culture. Cells adhered to microspheres (black asterisk) or as a connection between two or 
more microspheres (white asterisk). Scale bars: 50 µm. 
 
After 5 days of static culture, the presence of CPCs still adhering to gelatin/gellan 
microspheres functionalized with IGF-1 was observed. Cells did not show a round shape and 
were spreading their cytoplasm over the microsphere surface. Moreover, the presence of 
both cell-microsphere and cell to cell adhesion was noticed (Figure III.23). 
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Figure III.23. EGFPpos CPCs (green fluorescence) seeded on microspheres functionalized with IGF-1 d<90 µm 
after 5 days of static culture. Cells still adhere to microsphere surface, sometimes connecting cell to cell or cell 
to microsphere (white asterisk). Scale bars: 100 µm. 
 
Furthermore, it was observed that virtually CPCs were mainly conjugated with 
microspheres even if sometimes individual cells were observed to adhere to the dish for as 
long as 5 days of static culture. This finding suggests a stronger conjugation between single 
cells and microspheres, likely attributable to IGF-1 functionalization. 
 
Concerning cell-microsphere adhesion, a quantitative assessment of the conjugation of 
CPCs with microspheres was performed. Obtained results pointed out that after 24 hours of 
dynamic culture and after 5 days of static culture, a more efficient adhesion of CPCs to 
smaller microsphere was present. Moreover, an increased cell number was documented 
after 5 days of static culture, suggesting a positive effect of gelatin/gellan microspheres and 
dynamic culture in cell proliferation and survival (Figure III.24). 
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Figure III.24. Quantification of the fractional area occupied by EGFPpos CPCs after 24 hours of dynamic culture 
and after the following 5 days of static condition. 
 
- EGFPpos CPCs CTRL: after 24 hours of dynamic culture, the analysis by inverted microscope 
showed that EGFPpos CPCs were suspended as single cell; cluster formations were not 
observed. When seeded, they adhered and grew normally without differences from 
standard culture condition. 
 
Therefore, findings from preliminary experimental cellular tests established the ability of 
the bioreactor to guarantee the sterility and the viability of the cell culture, demonstrating 
the potentiality of this bioreactor that can be used as model system, both for testing 
cytocompatibility and durability of cell microcarriers (e.g. hydrogel microspheres) and for 
investigating the influence of suspension condition on cells, with or without microcarriers. 
In details, results also demonstrated the ability of the bioreactor to establish a biochemical 
and hydrodynamic environment suitable to maintain the cell-seeded microspheres in 
suspension condition within an appropriate 3D milieu. Moreover, the formation of small 
CPC spherical clusters highlights a potential role of the suspension conditions obtained 
within the bioreactor in creating a microenvironment suitable for stemness preservation.  
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4. Discussion and Conclusions 
 
Conventional in vitro 2D methods, characterized by a static environment with gradient 
concentrations, strongly differs from the 3D in vivo environment, where cells interact each 
other and with the extracellular matrix in a 3D perfused condition. Depending on the 
cultured cell types, the 2D unphysiological culture condition can lead to unnatural cell 
behaviors with altered cell morphology as well. For these reasons, many research groups 
have looked at developing 3D culture systems in the effort to replicate the 3D biochemical 
and biophysical native microenvironments. 
Suspension culture methods have become the most popular techniques for 
maintaining specialized features of cells (Hammond and Hammond, 2001), and, with or 
without microcarriers, they have been adopted for low cost scalable cell expansion and 
long-term cell viability maintenance (Amit et al., 2010; Zweigerdt et al., 2011; Consolo et al., 
2012; Olmer et al., 2012), for guiding differentiation of SCs (Siti-Ismail et al., 2012), for 
facilitating multicellular aggregate formation (Sen et al., 2001; Cameron et al., 2006; Wang 
et al., 2006), for preventing the dedifferentiation process that occurs under traditional 2D 
cell culture conditions (Hammond and Hammond, 2001), and for the production of native-
like 3D engineered tissues (Hwang et al., 2009; Yu et al., 2011) 
Since current suspension techniques suffer from some limitations, e.g., imposition 
of non-physiological shear stresses on cultured constructs (roller-bottles, stirred 
bioreactors), and expensive realization cost (rotating bioreactors), we have developed an 
innovative multipurpose and low-cost perfusion bioreactor.  
Previous studies have widely demonstrated that cells, and especially  CMs, need 
adequate oxygen supply to function efficiently (Carrier et al., 2002; Gerecht-Nir er al., 2006; 
Hecker et al., 2009). Therefore, the possibility to guarantee suitable oxygenation inside a 
bioreactor is an essential feature that need to be considered in the selection of a bioreactor 
configuration. Hence, we sized the perfusion subsystem in order to assure a suitable 
oxygenation of the cell culture, with a consequent proper cell viability, within the 
bioreactor culture chamber. Two different cases were considered: 1) a fixed number of 
cells, considering neonatal rat  CMs, and 2) a variable number of cells due to proliferation, 
modeling MSCs. Both studies allowed to find the correct balance among oxygen partial 
pressure of the medium, cell proliferation and tube length, defining the optimal operating 
conditions for guaranteeing oxygen level equal to 20%.  
Oxygenation is closely linked to the perfusion process within a bioreactor culture 
chamber. In fact, the beneficial effects of perfusion have been widely demonstrated. In 
cardiac TE several studies have shown as medium perfusion within suspension culture 
devices, by enhancing transport of nutrients and waste and providing flow-mediated 
mechanical stimuli, may benefit the in vitro development of 3D tissues and the generation 
of sufficient amounts of beating  CMs for use in cardiac TE (Xu et al., 2006; Niebruegge et 
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al., 2008; Haraguchi et al., 2013). Moreover, suspension culture with perfusion subsystem 
integrated generally produced higher cell numbers than static cultures and were able to 
achieve more aerobic metabolism than static and spinner flask cultures (Teo et al., 
2012).The perfusion subsystem has been implemented within our bioreactor for 
guaranteeing the suspension condition, and also due to its ability to enable a continuous 
transport of nutrients and supply culture parameters like pH, oxygen, and metabolites 
maintaining optimal operating conditions throughout the culture period.  
Bioreactor configurations that could provide a well-mixed environment have 
generally shown to improve proliferation of human-derived cell sources like embryonic SCs, 
(ESCs), MSCs and hematopoietic SCs (HSCs) (Chen et al., 2006; Yirme et al., 2008; Timmins 
et al., 2012). Differently, hydrodynamics in bioreactors can be optimized to alleviate 
problems related to static culture in conventional dish, as gradient concentrations and 
localized extremes that make large-scale bioprocesses difficult to monitor and control. 
Different bioreactor configurations will result in different flow patterns that can affect 
cellular activities. For example, hydrodynamics determines the macroscopic environmental 
conditions that will affect the shear stress and solute transport to the cells.  
Shear stresses introduced by the interaction of cells with fluid molecules and 
bioreactor walls could strongly influence the cell culture, since it poses a direct impact on 
cell viability and proliferation. It is therefore necessary to optimize the shear environment 
to ensure high proliferation and viability of the cell sources, and avoiding shear stresses 
higher respect to the detrimental values for the cells. It has been demonstrated, in fact, 
that shear stress values higher than 2.5 dyn/cm2 can cause cellular damage and reduce cell 
expansion for both human ESC and neonatal rat  CM cultures (Dvir et al., 2007; Millman et 
al., 2009; Lecina et al., 2010). Moreover, other studies have demonstrated as suspension 
systems with insignificant shear environment produced laminar flow profiles, which serve 
to minimize cellular damage and increase aerobic metabolism, and as a protective 
conditioning against apoptosis (Poelmann and Gittenberger-de Groot, 2005; Teo et al., 
2012).  
In order to investigate the hydrodynamics developing within the culture chamber, 
CFD simulations could provide a fundamental support. The high efficiency in computational 
methods enables rapid interrogation of multiple parameters such as mass transfer efficacy, 
oxygen distribution and shear stress in various bioreactor platforms. Findings from CFD 
simulations can provide relevant flow information to identify sensitive parameters that are 
significant to the hydrodynamics of the bioreactor, but can also serve to guide the design of 
a bioreactor for optimal cell culture (Teo et al., 2012). Accordingly, we performed CFD 
simulations for assisting the bioreactor design, for studying the microspheres-medium 
interaction, and for identifying the operating conditions that optimize mass transport e 
minimize shear stress. In this study the simulations do not take into account the presence 
of a cellular phase. However, the in silico set up could be upgraded in the future by 
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considering a cellular phase seeded on the suspended microspheres, and by evaluating cell 
oxygen consumption, as previously proposed (Consolo et al., 2012). Results concerning the 
shear stress distributions within the culture chamber, lower than 0,17 dyn/cm2, confirm the 
suitability of the device to avoid shear stress values critical for cultured cells. Results from 
preliminary cellular tests demonstrated the ability of the device to guarantee the sterility 
and the viability of the cell culture. Moreover, after 24 hours of dynamic culture CPCs were 
found organized in small spherical clusters, suggesting a possible role of the suspension 
conditions obtained within the bioreactor in creating a microenvironment suitable for 
stemness preservation, knowing that sphere formation in vitro is a characteristic feature of 
ESCs and adult SCs (Howson et al., 2005; Cormier et al., 2006; Gilbertson et al., 2006; zur 
Nieden et al., 2007; Ungrin et al., 2008; Kinney et al., 2011). Further cell culture experiments 
for testing the in vitro long-term viability maintenance and sterility, and for investigating 
the potentiality of the bioreactor as expansion/aggregation/differentiation system of 
tumorigenic cells (CALU-3, TEpC) and cardiospheres are ongoing and have demonstrated 
the ability of the bioreactor in maintain the cell culture viability and sterility up to 10 days. 
The findings of this study clearly demonstrated the suitability of the proposed innovative 
bioreactor. Thanks to its peculiar geometric features, the device assures the generation of 
buoyant vortices and the consequent establishment of suspension and low-shear 
conditions within the culture chamber, without using electromechanical systems. This 
innovative solution allows to provide a suitable biochemical and hydrodynamic 
environment for maintaining specimens of different dimensions in suspension conditions, 
guaranteeing suitable oxygen and nutrient mixing and transport, and avoiding shear stress 
values affecting the cells. The possibility to obtain suspension conditions with low-shear 
stress values just using different pressure gradients within the bioreactor, makes this device 
a low-cost and easy-to-use technological solution compared to the current available 
techniques.  
However, since our bioreactor still suffer from some limitations, future 
optimizations are now under consideration. First of all, the ability to incorporate in-situ 
monitoring of culture parameters is an essential component in bioreactor design. At the 
current stage, many real-time monitoring methods are available for bioreactors, including 
conventional electrochemical sensors, and non-invasive spectroscopic and optical 
technologies (Beutel and Henkel, 2011; Teixeira et al., 2011). Integration of real-time 
monitoring technologies should minimize the amount of sample extracted for analysis and 
any disruption to the cell culture itself. Alternatively in-situ probes may be incorporated into 
the bioreactor and this is one of the most favored designs. However, in-situ methods face 
the challenges of maintaining component sterility and its incorporation into the sterile 
environment of the bioreactor. The design of a minimally invasive yet reliable monitoring 
technique remains as one of the main challenges in TE (Teo et al., 2012). Within this scenario 
we are now investigating the possibility to implement specific sensors and control system 
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for the on-line, high throughput monitoring of basic parameters such as temperature, pH, 
partial pressure of oxygen (pO2) and of carbon dioxide (pCO2). These functioning modalities 
will be suitable for a lot of experiments aimed at investigated the environment within the 
culture chamber, providing the user with several quantitative data to be used to implement 
a control system of the experimental parameters. Finally, in the next future, in order to 1) 
reduce the quantity of cell culture medium for minimizing the experimental costs and the 
number of the bioreactor components for simplifying the use of the system by non-
experienced staff, and 2) insert an access side port for allowing cell samples/injections 
without interrupting the test, modifications of the bioreactor design will be considered.  
In conclusion, the innovative bioreactor developed has demonstrated the 
potentiality to be used as model system, both for testing cytocompatibility and durability of 
cell microcarriers (e.g. hydrogel microspheres) and for investigating the influence of 
suspension condition on cells, with or without microcarriers. Preliminary findings suggest 
that in the next future this bioreactor could be also used as an expansion, aggregation and 
differentiation system for in vitro cell culture. 
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APPENDIX III.A 
Sizing of the perfusion subsystem – Materials and Methods 
 
One of the critical aspects to take into account during bioreactor design is to ensure the 
adequate oxygenation of the cultured constructs. Therefore, trying to avoid problems 
related to poor oxygenation, such as cell death or the uneven growth of the tissue, it is 
fundamental to size the perfusion circuit of the designed bioreactor. 
The study, performed in accordance with Orr et al. (Orr et al., 2008), started from a 
simplified perfusion system (Figure III.A1), where is possible to identify three regions where 
oxygen exchange takes place.  
 
 
Figure III.A1. Simplified bioreactor system flow circuit. pO2(xt) is the partial pressure of oxygen dissolved in the 
medium at a given length xt. pO2 is the partial pressure of oxygen dissolved in the culture chamber. pO2(xb) is 
the partial pressure of oxygen dissolved in the reservoir. 
 
 
The first region is the culture chamber of the bioreactor, where medium gives oxygen to 
the constructs and receives carbon dioxide produced by cellular metabolism. The second 
region is represented by the oxygen-permeable tubes, that allow the oxygen exchange 
between the contained culture medium and the incubator atmosphere through their wall. 
Finally, the third region is identified by the free-surface medium reservoir. This latter gives a 
very low contribution to the oxygen exchange, therefore it was decided to neglect it. 
According to Orr et al. (Orr et al., 2008), the content of oxygen gas within the 
incubator atmosphere was considered to be constant over the duration of any given cell 
study. On the other hand, oxygen dissolved within the culture chamber decreased due to 
the cell consumption, while oxygen dissolved in the medium increased over length Δx 
representing fluid flow through the medium reservoir and silicone tubing, assuming a trend 
similar to the one shown in Figure III.A2.  
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Figure III.A2. Trend of the partial pressure of oxygen (PO2) along the entire length of the oxygen-permeable 
tubes. 
 
A Shell Balance has been constructed for the silicone tubing to define the oxygen-
permeable tubes' length, in order to obtain an oxygenation equal to the 98% of the oxygen 
saturation value dissolved within the medium. Assuming a steady-state situation 
(accumulation = 0), the balanced system for the silicone tubing was examined first using 
principles from Fournier and Basmadjian. 
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where           as determined by the Henry’s law, Q is the flow rate delivered by the 
pump, and H is the oxygen solubility within the culture medium at 37°C. 
It has been verified the laminar flow regime inside the tubes for a mean flow rate 
equal to 400 ml/min (Remean = 1337). In laminar flow conditions the velocity profile of the 
medium inside the tubes appears to be parabolic, and for the oxygen mass transport it is 
reasonable to apply the theory of the two films (Figure III.A3). 
 
 
Figure III.A3. Oxygen transport physical model through the wall of the silicone tube. 
 
 
Near the tube wall a zone of stagnant fluid can be considered (liquid film side). The same 
condition is present in the incubator side (gas side). Considering as control volume the 
portion between the two films (gas and liquid film side) and the membrane wall, assuming 
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the absence of oxygen accumulation inside the volume, the oxygen flow (NAvg) that crosses 
the side gas is equal to the one that crosses both the liquid film side and the tube wall. 
Therefore, NAvg can be expressed with equation 3. The gaseous exchange through the 
permeable tubes is driven by the partial pressure difference between the incubator side 
(gas) and the medium side (liquid). Assuming a constant concentration on each cross 
section of the tube (1D approximation model), the oxygen flow at each section positioned 
at the coordinate xt is expressed by the relation 
 
             (   
          )                                                           
where the area of the tubing wall is defined by the product of the log mean of the inner and 
outer tubing circumference, W, and the change in the tubing length, Δxt. KOL is the overall 
mass transfer coefficient. Its inverse (the resistance to the mass transfer coefficient) takes 
into account the resistance to transport liquid side, solid side, and of the tube wall (function 
of its permeability): 
 
 
   
  
 
  
  
    
       
  
    
    
                                                                  
where: 
 Wi, Wo are the inner and outer tubing circumference, respectively;  
 ρSTP is the gas density at 0° C and 1 atm;  
 R is the gas constant;  
 T is the incubator temperature;  
 Pm is the silicone tubing oxygen permeability, which is normalized by the wall thickness;  
 tm is the thickness of the tube;  
 Ki is the mass transfer coefficient of the inner layer;  
 Ko is the mass transfer coefficient of the outer layer.  
The three summations in the equation 4 can be individually associated with the three layers 
reported in Figure III.A3. In fact, the model uses three layers representing the ideal barriers 
through which mass is exchanged between the atmosphere of the incubator and the 
medium inside the tubes. In detail, the middle layer is the tube wall and is associated with 
the central term of the equation 4. 
 
(
    
       
)                                                                                                       
 
This term represents the oxygen permeability of the tube wall, which is closely related to 
the thickness of the tube and its coefficient of permeability. 
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The first term of equation 4 is associated with the tube inner layer and represents the 
region of stationary fluid near the wall: 
 
 
  
                                                                                                                          
 
This region is generated by friction between the stationary fluid in laminar flow and inner 
wall of the tube.  
In order to determine the Ki (liquid film side) coefficient it is necessary to calculate the 
Reynolds number: 
 
    
    
 
                                                                                                         
The density ρ and viscosity μ are assumed equal to 1 g/cm3 and 0.01 g/cm*sec, respectively, 
and the term V is the mean velocity of fluid in the tube section; if Re < 2100 the flow can be 
considered laminar, and stagnant layer of fluid near the wall is present. The coefficient Ki is 
then calculated taking into account the correlation existing between Sherwood, Schmidt 
and Reynolds dimensionless numbers. The Sherwood number is calculated from the 
following correlation: 
 
                                                                                                 
where Sc is the Schmidt number expressed as: 
    
 
   
                                                                                                           
and Dm is the oxygen medium diffusion coefficient at 37°C. 
The Shell Balance in equation 1 can be reformulated by combining it with the equation 3: 
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by integration is obtained 
            
        
          
     
                                                    
 
In this equation, pO2(xt) is the partial pressure of oxygen dissolved in the medium at a given 
length xt, pO2’ is the partial pressure of oxygen in the gaseous phase (incubator), and pO2o is 
the level of oxygen in the medium at the entrance of the tube (that coincides with the 
partial pressure of oxygen at the exit of the culture chamber). 
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To determine the pO2o value is necessary to impose a new Shell Balance within the 
volume of the culture chamber. A cellular component composed by neonatal rat  CMs was 
considered, and the oxygen metabolic consumption value was obtained from literature 
(Chlopčíková et al., 2001). The partial pressure pO2o can be expressed as 
 
               
           
         
                                                                       
 
where Ncell is the cell number injected, γcell is the oxygen metabolic consumption rate for 
neonatal rat  CMs (Chlopčíková et al., 2001), and Vchamber in the volume of medium within the 
culture chamber. 
Combining equation 11 and 12 is possible to determine the length of the tube 
necessary for guaranteeing the proper culture medium oxygenation (pO2(xt)), following the 
oxygen metabolic consumption caused by the cellular component within the culture 
chamber. 
 
      
 
     
  
   
          
   
       
                                                                
 
In Table III.A1 and Table III.A2 the model parameters and the flow rate values with the 
corresponding Sherwood medium number, mass transfer coefficient Ki, overall mass 
transfer coefficient KOL, and resistance to the mass transfer coefficient 1/KOL are 
summarized: 
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Table III.A1. Fluid dynamic and consumption model parameters. 
Fluid dynamic parameters Consumption model parameters 
H (mmHg/µM) 0.74 Ncell 6 x 10
5 
pO2’ (mmHg) 141 γcell (mol/cell s) 5.44 x 10
-7 
pO2 (xt) (mmHg) 138.18 Vchamber (cm
3) 50 
Tm (cm) 0.159   
Wi (cm) 1.995   
Wo (cm) 2.991   
W (cm) 2.459   
ρSTD (mol/cm
3) 4.46 x 10-5   
R (mmHg/(mM K)) 6.24 x 10-2   
T (K) 310   
Pm (cm2/mmHg s) 7.96 x 10
-8   
di (cm) 0.635   
do (cm) 0.952   
ρ (g/cm3) 1   
µ (g/cm s) 0.01   
Do2/aria (cm
2/s) 0.21   
Do2/medium (cm
2/s) 2.18 x 10-5   
Sharia 0.43   
Ko (cm/s) 0.094   
 
Table III.A2. Flow rate values with the corresponding Sherwood medium number, mass transfer coefficient Ki, 
overall mass transfer coefficient KOL, and resistance to the mass transfer coefficient 1/KOL. 
Q 
(ml/min) 
Shmedium Ki  
(cm/s) 
KOL 
(mM cm/mmHg s) 
1/ KOL  
(mmHg s/mM cm) 
400 149,54 3,42*10-3 3,96*10-6 2,52*105 
300 129,57 2,97*10-3 3,50*10-6 2,86*105 
200 105,87 2,42*10-3 2,93*10-6 3,42*105 
100 74,99 1,72*10-3 2,14*10-6 4,67*105 
90 71,16 1,63*10-3 2,04*10-6 4,90*105 
80 67,12 1,54*10-3 1,93*10-6 5,18*105 
70 62,81 1,44*10-3 1,82*10-6 5,51*105 
60 58,18 1,33*10-3 1,69*10-6 5,92*105 
50 53,15 1,22*10-3 1,55*10-6 6,44*105 
40 47,58 1,09*10-3 1,40*10-6 7,15*105 
30 41,27 9,45*10-4 1,22*10-6 8,19*105 
20 33,77 7, 73*10-4 1,01*10-6 9,93*105 
10 24,01 5,50*10-4 7,23*10-7 1,38*106 
 
Sizing of the perfusion subsystem - Results 
 
In order to guarantee a good cell viability by ensuring an adequate supply of oxygen and 
nutrient within the culture chamber, the perfusion subsystem was sized. Two different 
cases have been analyzed: the first one without take into consideration cell proliferation, 
Chapter III – An innovative suspension bioreactor 
139 
 
whereas the second one considering the cell proliferation in order to take into account the 
effective experimental test condition.  
For the first case, equation 13, the parameters summarized in Tables III.A1 and III.A2, 
and a partial pressure of oxygen (pO20) at the end of the tubes equal to the 98% of the 
saturation (138,18 mmHg) were considered. The oxygen exchange due to the free-surface 
reservoir equal to 0,22 mmHg was neglected. 
Table III.A3 reported the lengths of the tubes obtained for each flow rate considered. 
 
Table III.A3. Tube lengths for each flow rate considered. 
Q (ml/min) pO20 Tube length (cm) 
400 138,18 0,1 
300 138,18 0,2 
200 138,18 0,2 
100 138,18 0,3 
90 138,18 0,3 
80 138,18 0,3 
70 138,18 0,3 
60 138,18 0,3 
50 138,18 0,4 
40 138,18 0,4 
30 138,18 0,5 
20 138,18 0,6 
10 138,18 3,4 
 
Considering the second case, it is possible to assume that, if a suitable environment 
establishes within the culture chamber of the bioreactor, during cell culture cells proliferate 
over time, increasing in number. Therefore, the cell metabolic volumetric oxygen 
consumption rate will increase and should be considered in the calculation of the necessary 
tube length for assuring the correct oxygen supply for cell viability. Figure III.A4 shows an 
overview of the process and the variables involved. 
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Figure III.A4. Assumption of oxygen replacement in case of cell proliferation; the grey lines represent three 
different cycles of the culture medium in the bioreactor. The black line represents the constant partial pressure 
of oxygen within the incubator. 
 
The graph represented in Figure III.A4 shows as, after a series of cycles of the cell culture 
medium within the perfusion subsystem, there is the possibility that the oxygen 
consumption is higher than that which can be guaranteed maintaining fixed the length of 
the tubes. In the graph, the grey lines characterize three different cycles of the culture 
medium within the bioreactor, representing the variation of the partial pressure of oxygen 
within the tube at increased instants of time. On the other hand, the black line represents 
the partial pressure of oxygen within the incubator, which is maintained constant for all the 
experimental test.  
Observing this graph, is possible to determine whether the oxygenation conditions 
are always maintained at acceptable levels within the culture chamber, guaranteeing 
suitable cell culture conditions. Contrarily, taking into account the cell proliferation, there is 
the possibility that the length of the tubes doesn’t ensure the suitable oxygenation, 
bringing the system in hypoxia condition, that occurs for values of partial pressure of 
oxygen lower than 60 mmHg. Therefore, in order to understand the trend of the partial 
pressure of oxygen within the culture chamber for a long-term experiment, study was 
performed. The following equation allows to estimate the cell proliferation trend, modeling 
MSCs: 
 
             
                                                                                                 
 
Where Cx(0) and Cx(t) represent the cell number at the start and at the end of the 
exponential growth phase, respectively, μ represents the specific growth rate (h-1) and t 
indicates the time (h) of culture. The value of the growth rate (μ) was assumed equal to 
0,22 h-1 according to the work of Schop (Schop, 2010). Assuming to calculate the 
proliferation each 1, 4, 8, 16, 24, 36, and 48 hours, and having an initial number of cells equal 
to 6x105, the following proliferation trend is obtained (Figure III.A5). 
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Figure III.A5. Cell proliferation trend. 
 
This proliferation trend is based on the assumption that at each step the cells proliferate 
similarly, without considering the achievement of the confluence. These data were used to 
calculate the oxygen consumption at different time step, and the respective length of the 
tubes necessary to re-establish the optimal oxygenation. In Table III.A4 the tube lengths for 
each cell proliferation step are summarized. 
 
Table III.A4. Tube lengths for each flow rate and number of cells considered. 
Tube 
length 
(cm) 
Number of cells 
6*105 6,12*105 6,50*105 7,04*105 8,26*105 9,70*105 1,23*106 1,57*106 
Fl
o
w
 r
at
e
 (
m
l/
m
in
) 
400 0,1 0,1 0,2 0,2 0,2 0,2 0,3 0,4 
300 0,2 0,2 0,2 0,2 0,2 0,3 0,3 0,4 
200 0,2 0,2 0,2 0,2 0,3 0,3 0,4 0,5 
100 0,3 0,3 0,3 0,3 0,4 0,4 0,6 0,7 
90 0,3 0,3 0,3 0,3 0,4 0,5 0,6 0,7 
80 0,3 0,3 0,3 0,4 0,4 0,5 0,6 0,8 
70 0,3 0,3 0,3 0,4 0,4 0,5 0,7 0,8 
60 0,3 0,3 0,4 0,4 0,5 0,6 0,7 0,9 
50 0,4 0,4 0,4 0,4 0,5 0,6 0,8 1 
40 0,4 0,4 0,4 0,5 0,6 0,7 0,8 1,1 
30 0,5 0,5 0,5 0,6 0,7 0,8 1 1,2 
20 0,6 0,6 0,6 0,7 0,8 0,9 1,2 1,5 
10 3,4 3,5 3,7 4 4,7 5,5 7 8,9 
 
Chapter III – An innovative suspension bioreactor 
142 
 
Data obtained allow us to conclude that with our tube lengths we are always in safe 
conditions, guaranteeing the proper oxygenation to the cultured proliferating cells. 
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Abstract 
 
 
Cardiac tissue engineering has shown the potential to generate thick-contractile 
myocardium-like constructs that might be used as functional substitute or as biological in 
vitro model system to investigate the tissue-specific development and diseases, and to 
offer accurate and controlled in vitro tests for cell and tissue-based therapies, drug 
screening, predictive toxicology and target validation. The requirements for engineering 
clinically sized cardiac constructs include the use of biomaterials that might present native-
like tissue mechanical properties and/or topographical cues, the application of physiologic 
conditions such as perfusion, electrical and mechanical stimulation during cell culture, and 
the choice of a cell population. As a proof-of-principle to engineer thick-relevant skeletal 
myoblast-based contractile three-dimensional patches we investigated if these 
requirements can be met by combining cell density, cell culture medium composition, 
perfusion-based bioreactor culture system parameters, and type I collagen scaffold. We 
demonstrate that this combined approach resulted in increased viability, and functionality 
of the cardiac patch. After 6 days of perfused culture within a bioreactor-based culture 
system, skeletal myoblast-seeded on millimiter-thick cardiac patches displayed significantly 
improved viability, survival and differentiation of skeletal myoblasts, leading to greatly 
enhanced contractility. Perfusion also improves the seeding phase, resulting in a more 
homogeneous distribution of the cells within the entire volume of the scaffold. We propose 
that these techniques can be utilized to engineer reproducible thick-relevant and compact 
skeletal myoblast-based contractile three-dimensional patches, for the formation of 
engineered cardiac tissue to be used as functional substitute or as biological in vitro 
research model system.  
 
Keywords: cardiac tissue engineering, bioreactor, perfusion, differentiation, skeletal 
myoblasts. 
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1. Introduction 
 
Cardiac tissue engineering (TE) has shown the potential to generate functional 
myocardium-like constructs that might be used as functional substitute or as biological in 
vitro model system (Bursac et al., 1999; Habeler et al, 2009; Smits et al., 2009; Hirt et al., 
2012), e.g. for drug screening, predictive toxicology and target validation (Elliot and Yuan, 
2010; Hansen et al., 2010).  
Cardiac TE implies the use of biomaterials that might present native-like tissue 
mechanical properties and/or topographical cues (Kim et al., 2010), as well as applying 
physiologic conditions such as perfusion (Radisic et al., 2008), electrical (Tandon et al., 
2009) and mechanical stimulation (Fink et al., 2000; Zimmermann et al., 2002a; Gonen-
Wadmany et al., 2004; Birla et al., 2007) during cell culture (Chiu and Radisic, 2013, Massai et 
al., 2013).  
The choice of which cell population to employ for cardiac TE should met some key 
requirements as the availability in large numbers and the ability to differentiate into cardiac 
lineages able to survive and function (Vunjak-Novakovic et al., 2010; Chiu and Radisic, 2013). 
Neonatal rat cardiomyocytes are often chosen for their natural electrophysiological, 
structural, and contractile properties (Zheng et al., 2012; Ravichandran et al., 2013), 
however they have a limited capacity to proliferate and not clinical relevance. Embryonic 
stem cells (ESCs) (Boheler et al., 2002; Mummery et al., 2002; Guo et al., 2006; Zimmermann 
and Eschenhagen, 2007) and induced pluripotent stem cells (iPSCs) (Mauritz et al., 2008, 
Narazaki et al., 2008; Martinez-Fernandez et al., 2009; Zwi-Dantsis et al., 2011) represent 
valid cell candidates for cardiac TE thanks to their autologous nature, ability to propagate in 
large quantities, and to differentiate into cardiomyocytes. However, their still high risk of 
tumorigenicity and the complexity of their differentiation protocols still make it not an easy 
cell source to be used for safe and standardized cardiac TE. Human adult stem cells (Scs) 
share most of the positive features with iPSCs making them an eligible cell candidate for 
cardiac TE with the extra benefit of low oncogenesis, but have shown to have still a limited 
and not highly reproducible in vitro differentiation potential into fully mature 
cardiomyocytes (Orlic et al., 2001; Beltrami et al., 2003; Planat-Benard et al., 2004). Skeletal 
myoblasts (SMs) are widely use in cardiac TE thanks to their high proliferative potential, 
high resistance to ischemia, and their fate restriction to the myogenic lineage, with the 
capacity to develop a complete contractile apparatus, virtually eliminates the risk of 
tumorigenicity (Menasché, 2004; 2008). On the other hand, the major disadvantage of SMs 
is that they do not electrically couple with the host cardiomyocytes (Durrani et al., 2010), 
and this obviously raises the major question of the mechanisms by which, in case of cell 
transplantation, the myoblasts can improve left ventricular function (Manasché, 2004). 
Despite this concern, several research groups have demonstrated the ability of SMs to 
partially treat cardiomyopathies both in small (Khan et al., 2007; Al Attar et al., 2003; Ye at 
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al., 2005; Taylor et al., 1998; McCue et al., 2008) and large animal models (Ghostine et al., 
2002; Haider et al., 2004; Brasselet et al., 2005; He et al., 2005; Hata et al., 2006; Ye et al., 
2007). However, cell transplantation often results in tissue damage and poor cell 
engraftment limiting therefore the potential application of SM-associated therapies (Hamdi 
et al., 2011). Cardiac TE might overcome this limitation by culturing progenitor cells on 
biomaterial scaffolds (designed to provide a structural and logistic template for tissue 
development) in bioreactors (designed to control cellular microenvironment, facilitate mass 
transport to the cells and provide the necessary biochemical and physical regulatory 
signals) in order to develop in vitro an appropriate cell environment to support both cell 
survival and differentiation upon implantation (Siepe et al., 2007, Hamdi et al., 2011). Several 
studies have demonstrated as SMs seeded on polymeric scaffolds, as polyurethane, or 
biological scaffolds, as collagen type I, implanted on infarcted hearts, were able to migrate 
from the patch to the damaged myocardium (Siepe et al., 2007; Kroehne et al., 2008; Ma et 
al., 2011). Improved functions were later observed by statically loading genetically modified 
SMs on three-dimensional (3D) scaffolds, obtaining an enhanced angiogenesis, and a 
reduced infarction zone (Blumenthal et al., 2010; von Wattenwyl et al., 2012).  
Based on our knowledge, 3D SM-based constructs have been generated only by 
static condition until now, whereas bioreactor-based culture could offer a high control over 
the culture parameters and therefore lead to a standardized and reproducible production 
process. In particular, perfusion-based bioreactor methods for cell seeding and culture 
result in an increase of cell loading efficiency, and in the formation of functional cardiac 
engineered tissue with a relevant thickness by promoting homogeneous distribution of 
oxygen and nutrients, and in enhanced expression of cardiac-specific markers (Carrier et al., 
1999; 2002a; 2002b; Radisic et al., 2003). In this study, we therefore aim to investigate the 
perfusion-based culture parameters suitable to engineer reproducible thick-relevant 
contractile 3D patches starting with mouse SMs and type I collagen scaffold. In particular, 
we focused on the influence of initial cell density and of different culture medium 
composition on the ability of SMs to proliferate and differentiate into contractile units in a 
3D bioreactor-based culture system. 
 
2. Materials and Methods 
 
2.1 Cell culture 
 
Primary myoblasts isolated from C57BL/6 mice were transduced with a retrovirus 
expressing the β-galactosidase (LacZ) marker gene, as previously described (Rando and 
Blau, 1994), and cultured in 5% CO2 on collagen-coated dishes, with a growth medium 
consisting of 40% DMEM low glucose (Sigma-Aldrich Chemie GmbH, Steinheim, Germany), 
40% (v/v) F-10 (Sigma-Aldrich Chemie GmbH, Steinheim, Germany), 20% (v/v) FBS (HyClone, 
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Logan, UT), supplemented with 2.5 ng/ml FGF-2 (R&D Systems, Abingdon, UK), 1% (v/v) P/S, 
and 1% (v/v) glutamine. When 70% confluence was reached, cells were detached by using 
0.25% (w/v) trypsin/0.1% (w/v) EDTA and then used in the experiment. 
 
2.2 Polymer scaffold 
 
In this study a commercially available type I collagen scaffold (Ultrafoam® collagen 
hemostat from Davol Inc., Cranston, RI), highly porous material, ~ 90% void volume with 
interconnected pores 100–200 µm in diameter (Radisic et al., 2003; Meinel et al., 2004a; 
2004b), was used as discs of 12 mm diameter, 3 mm thickness. Immediately before use, 
each collagen scaffold was hydrated in culture medium (24 h in the 37°C at 5% CO2 
humidified incubator). 
 
2.3 Perfusion-based bioreactor culture system 
 
For the direct perfusion of a cell suspension through the pores of 3D scaffolds, a previously 
developed bioreactor was used (Wendt et al., 2003). As shown in Figure IV.1, scaffold was 
placed between two silicon O-rings which were holding it in place and allow perfusion of 
the medium through the collagen sponge voids, as shown in Figure IV.1. Therefore, only the 
inner 8-mm core of collagen scaffolds was directly perfused. The polycarbonate culture 
chamber that was attached to two silicone columns and connected to a syringe pump 
(Programmable Harvard Apparatus PHD ULTRATM 2000) 
 
 
Figure IV.1. Positioning of the scaffold within the polycarbonate bioreactor culture chamber. 
 
2.4 Cell preparation and scaffold seeding 
 
Engineered constructs were prepared using SMs. Scaffolds were placed into custom 
produced chambers of the perfusion-based bioreactor culture system, and seeded with a 
cell density of 2.2 x 106 or 3.3 x 106 cells per scaffold and at a forward-reverse flow rate of 
3ml/min for 24 hours, as described in previous studies (Scherberich et al., 2007). The cell-
seeded constructs were then cultured with a bidirectional perfusion flow rate of 0.15 
ml/min for an additional 5 days. Depending on the experiment, cells were seeded and 
cultured on the scaffolds in either of the following media: (a) SM proliferation medium 
Chapter IV – Generation of contractile 3D muscle-like tissue in a perfusion-based bioreactor 
culture system 
159 
 
(PM) consisting of 40% DMEM low glucose (Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany), 40% (v/v) F-10 (Sigma-Aldrich Chemie GmbH, Steinheim, Germany), 20% (v/v) FBS 
(HyClone, Logan, UT), supplemented with 2.5 ng/ml FGF-2 (R&D Systems, Abingdon, UK), 
(b) SM differentiation medium (DM) containing 95% DMEM low glucose (Sigma-Aldrich 
Chemie GmbH, Steinheim, Germany), 5% (v/v) horse serum (Invitrogen, Basel, Switzerland), 
and (c) a SM complete medium (CM) consisting of 90% DMEM high glucose (Sigma-Aldrich 
Chemie GmbH, Steinheim, Germany), 10% (v/v) FBS (Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany). All media were supplemented with 1% (v/v) P/S, and 1% (v/v) 
glutamine. Cell culture medium was changed every 2/3 days. 
Layout of the experimental plan is reported in Figure IV.2. 
 
 
Figure IV.2. Layout of the experimental plan. 
 
2.5 DNA quantification 
 
One half of each construct was weighed and digested overnight at 57°C in 1 mL of 
proteinase K solution (1 mg/ml proteinase K, 50 mM TRIS, 1 mM EDTA, 1mM iodoacetamide, 
and 10 µg/ml pepstatin-A; Sigma-Aldrich, USA) in double distilled water or potassium 
phosphate buffer. DNA quantification was performed by means of a commercially available 
fluorescence based kit, namely CyQUANT® Cell Proliferation Assay (Invitrogen, 
Switzerland). Working solutions were prepared according to the manufacturer’s protocols. 
The analyses were carried out measuring fluorescence with a Spectra Max Gemini XS 
Microplate Spectrofuorometer (Molecular Devices, USA). Excitation and emission 
wavelengths were respectively 485 nm and 583 nm. Samples in each plate included a 
calibration curve. Each sample was measured in triplicate.  
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2.6 Cell seeding efficiency 
 
The seeding efficiency, defined as the percentage of initially seeded cells that attached to 
the scaffolds, was determined by comparing the DNA content present in each scaffold after 
24 h of perfusion seeding to the reference DNA value determined for aliquots of the 
seeding cell suspension. For reference samples (corresponding to the total amount of cells 
loaded per scaffold), cells were centrifuged to obtain pellets, digested in 1 mL of proteinase 
K solution (1 mg/ml proteinase K, 50 mM TRIS, 1 mM EDTA, 1mM iodoacetamide, and 10 
µg/ml pepstatin-A; Sigma-Aldrich, USA), and analyzed using the CyQUANT® Cell 
Proliferation Assay (Invitrogen, Switzerland). As these samples contained the same number 
of cells initially seeded per scaffold, they served as a reference (100% value) for seeding 
efficiency. For cultured constructs, samples were cut in half and weighed, digested in 1 mL 
of proteinase K solution, and analyzed using the CyQUANT® Cell Proliferation Assay 
(Invitrogen, Switzerland). Working solutions were prepared according to the 
manufacturer’s protocols. The analyses were carried out measuring fluorescence with a 
Spectra Max Gemini XS Microplate Spectrofuorometer (Molecular Devices, USA). Excitation 
and emission wavelengths were respectively 485 nm and 583 nm. The linear relationship of 
the CyQuant fluorescence with the cell number allowed us to directly calculate the seeding 
efficiency as the ratio of measured values.  
 
2.7 Immunofluorescence microscopy and quantitative analysis of myotubes 
 
For fluorescence imaging, one half of each cultured scaffold was fixed overnight in 1% 
parafolmaldehyde, and the second day again overnight in 30% sucrose All the previous step 
were performed at 4°C. The third day cultured scaffolds were embedded in OCT (CellPath, 
Newtown, Powys, UK), sectioned in 10 and 25 μm thick sections through the cross-section 
of the scaffold by means of a cryostat (Microm International GmbH, Walldorf, Germany). 
Construct sections were incubated for 1 h in 0.3% Triton X-100 and 2% normal goat serum in 
PBS (at room temperature), and then for 1 hour (at room temperature) in mouse 
monoclonal anti-desmin (Mubio Products, Switzerland) primary antibody at 1:100. 
Subsequently, tissue sections were incubated in dark for 1 h (at room temperature) in 
Alexa546 anti-mouse (Invitrogen, Switzerland) secondary antibody at 1:200. Nuclei were 
stained using DAPI (Invitrogen, Switzerland) at 1:50 for 1 h (at room temperature). 
Antibodies were diluted in 0.3% Triton X-100 and 2% normal goat serum in PBS. Fluorescence 
images were taken with 20x on an Olympus BX63 Apollo fluorescent microscope (Olympus, 
Volketswil, Switzerland). All image analyses were performed using ImageJ 1.47 software 
(Research Service Branch, NIH, USA). 
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2.8 Calculation of fusion and maturation indices 
 
The fusion index was calculated as the ratio of the nuclei number in desmin-positive 
myocytes with two or more nuclei versus the total number of nuclei (Bajaj et al., 2011). The 
maturation index was defined as myotubes having five or more nuclei (Bajaj et al., 2011). 
The graphs were created in GraphPad Prism 5 (GraphPad Software Inc., USA), and 
Photoshop CS5 (Adobe Photoshop Software Inc., USA) was used for assembly of figures. 
 
2.9 In vitro contractility assessment  
 
The assessment of the in vitro contractility was performed in organ baths (TSE, Bad 
Homburg) containing 12 ml of KH solution 20x, 4.2g of sodium bicarbonate, 4g of glucose, 
1.25 mM Cacl2, sodium L-ascorbate in deionized water at 37°C equilibrated with Carbogen 
Gas (95% O2; 5% CO2). Cultured scaffolds were punched at 8 mm diameter and attached 
vertically between a rigid and a mobile fastening (steel hooks) as shown in Figure IV.3. 
 
 
Figure IV.3. Picture of the organ bath set-up.  
 
The latter was connected to a force transducer. The constructs were preloaded with a force 
of 300 mg and electrically paced with rectangular pulses (10 ms pulse duration, 100 mA 
pulse amplitude) field stimulation at 1 Hz. The contractility measured by the force 
transducers was continuously recorded on a PC using BioSys-software (TSE, Bad Homburg) 
with or without the application of electrical stimulation (ES). Functionality was assessed in 
duplicates. The amplitude of contraction was then measured as the maximum minus the 
minimum force recorded in mg.  
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2.10 Statistical analysis 
 
Data were analyzed using the analysis of variance one-way ANOVA followed by Bonferroni’s 
post-hoc tests for multiple comparison using GraphPad Prism 5 (GraphPad Software Inc., 
USA). Results were considered statistically significant when the p value was less then 
(p<0.05). The data are shown as mean ± standard error on the mean (SEM). The number of 
replicate experiments performed is given as n. 
 
3. Results 
 
3.1 Evaluation of cell-scaffold interaction 
 
Two different cell densities were investigated to define the suitable initial cell number 
(assessed by cell seeding efficiency) to support SM differentiation (assessed by 
immunofluorescence for desmin). When 2.2 x 106 cells were loaded per scaffold, the 
seeding efficiency was found to be higher than 70%, corresponding to an average of ~1.54 
millions of adherent cells, but no differentiation in myotubes and neither construct 
contraction were observed (data not show). However, when 3.3 x 106 cells/scaffold were 
used, cell seeding efficiency was found to be higher than 55%, corresponding to ~1.8 million 
cells attached to the scaffold and the resulting engineered constructs were capable to 
contract. These results suggested that there might be an upper limit of cell number which is 
feasible to be loaded at one time on collagen disc of 8 mm diameter and 3 mm thickness. 
The cell density of 3.3 x 106 cells/scaffold resulted to maximize seeding efficiency and 
differentiation process, while minimizing cell waste, and thus this seeding density was used 
for the subsequent experiments. 
In vitro two-dimensional (2D) SM differentiation highly depends on the initial cell 
density and on the supplementation of serum in the culture medium. In our bioreactor 3D 
culture system, we investigated the fate of SMs when cultured in 3D with a medium either 
pushing SM proliferation or SM differentiation or a medium normally used for stem cell or 
neonatal CM culture for up to 6 days under perfusion. As shown in Figure IV.4, DNA 
quantification results indicated that the cell number was higher when cultured with PM or 
CM as compared to DM after 5 days of culture. The cell number presents on the constructs 
cultured for 5 days with DM corresponded to only the 3.4% of the cells initially adherent to 
the scaffold. 
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Figure IV.4. Total DNA quantification analyses. Significance: *** p <0.001, and ns = not significant. Data are 
represented as mean ± SEM. (n = 3). 
 
Taken together, these results demonstrated the feasibility to appropriately seed SMs on 
the porous collagen substrate and suggest the possibility to regulate their growth fate with 
the use of exogenous factors during the perfusion culture. 
 
3.2 Fusion and maturation indices of SM 
 
When deprived of serum SMs undergo cell cycle arrest and start to fuse together to form 
long multinucleated myotubes, useful as contractile unites, and as the building blocks for 
cardiac muscle. Desmin specific staining was used to assess the initial SM fusion into 
myotubes. Immunofluorescent staining for desmin and nuclei showed that cells were 
spatially uniformly distributed throughout the entire volume of the constructs, as expected 
after the culture in a perfusion-bioreactor system. Cells positive for desmin were also 
present uniformly throughout the cross section of the generated constructs. However, 
tissues engineered in CM resulted to have higher amount of desmin-positive cells (Figure 
IV.5). 
 
 
Figure IV.5. SM differentiation. Fluorescent images for desmin of the SM cultured on the collagen scaffolds with 
different cell culture medium: PM (A) or DM (B) or CM (C). Cells were stained for anti-desmin (red) and DAPI 
(blue). Scale bar = 50 µm. 
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To assess and quantify the differentiation of myotubes, we calculated the fusion index 
determining the number of nuclei in the desmin stained myotubes (only cells with ≥ 2 nuclei 
were used) normalized to the total number of nuclei in the field of view. The results 
reported in Figure IV.6 show a progressive increase in myotube differentiation starting with 
the PM followed by DM and CM. CM (3.74 ± 0.34) showed greater than 3 and 2-fold 
differentiation compared to PM (1.24 ± 0.22) and DM (1.87 ± 0.41), respectively. The 
maturation index (% of myotubes ≥ 5 nuclei) was also used as a parameter to evaluate the 
differentiation of SMs. The maturation index can also be used to quantify the size of the 
myotube, a higher maturation index represents myotube larger in size (Sun et al, 2010; Bajaj 
et al., 2011) (Figure IV.6). Constructs generated in CM resulted to have both the highest 
fusion and maturation index. The maturation index for the CM (28.26 ± 2.41) was 
statistically higher than that for the PM (9.44 ± 0.78), and DM (20.65 ± 2.84).  
 
Figure IV.6. Quantification of the fusion and maturation index for the SM cultured with different cell culture 
medium. (A) Fusion Index. The fusion index was calculated as the ratio of the nuclei number in myocytes with 
two or more nuclei versus the total number of nuclei. (B) Maturation Index. The maturation index was defined 
as myotubes having five or more nuclei. Significance: *** p < 0.001, ** p < 0.01, * p < 0.05, and ns = not 
significant. Data are represented as mean ± SEM. (n = 3). 
 
3.3 In vitro assessment of the contractility 
 
Engineered constructs cultured in CM resulted also to contract better than those generated 
in PM either with or without the application of ES (Figure IV.7). Engineered tissues 
generated in DM did not contract spontaneously or after pacing. Those functional results 
are in agreement with the maturation and fusion index results assessed by image analysis 
(Figure IV.6). 
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Figure IV.7. Graph representing the amplitude of contraction force (expressed in mg) of SM-based constructs 
cultured in CM or PM assessed in organ bath with (+ES) or without (-ES) electrical stimulation (+ES corresponds 
to the stimulation with a pulse of 10 ms duration and 100 mA of amplitude at the frequency of 1 Hz). 
Significance: * p < 0.01 and *** p < 0.0001. Data are represented as mean ± SEM. (n = 3). 
 
 
4. Discussion  
 
In this study, we have demonstrate the possibility to engineer thick-relevant SM-based 
contractile 3D patches to be used as functional substitutes or as biological in vitro research 
model systems in perfusion-based bioreactor. We identify the CM as the most suitable 
culture condition among those investigated to promote both SM growth and 
differentiation, leading to a significant functional improvement. It is well known the crucial 
role of cell culture medium composition in SM differentiation (Goto et al., 1999; Portiér et 
al., 1999; Lawson and Purslow, 2000; Yoshiko et al., 2002); however, in static culture 
conditions we do not observe similar effects than in perfusion culture with the same use of 
medium composition. Perfusion culture and 3D system might have a crucial effect. Notably, 
the effect induced by the perfusion stimulation was efficient enough to allow survival and 
differentiation of the SMs inside a millimeter-thick cardiac patch and therefore contractility 
of the cardiac patches. 
Over the past decade, advances in the field of cardiac TE have been achieved 
through the application of various types of biophysical stimuli: electrical (Radisic et al., 
2004), mechanical (Zimmermann et al., 2002b), and hydrodynamic (Carrier et al., 2002b), via 
specialized bioreactors. Generally, the bioreactor designs have been motivated by the 
understanding of the native cardiac environment, and the notion that the factors present in 
the developing cardiac tissue in vivo need to be recapitulated to engineer functional cardiac 
tissues in vitro.  
Among these biophysical stimuli, the hydrodynamic one obtained through 
perfusion-bioreactor, by reducing diffusional gradients associated with mass transport over 
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macroscopic distances and improving control of local levels of pH and oxygen, is essential 
to maintain the viability and function of cardiac patches. Previous studies demonstrated 
that perfusion improves cell seeding efficiency throughout the thickness of 3D scaffolds, 
promotes homogeneous distribution of oxygen within a bioreactor culture chamber, 
increases construct thickness, enhances the expression of cardiac-specific markers (Carrier 
et al., 1999; 2002a; 2002b; Radisic et al., 2003), and guarantees high cell viability by 
protecting cells from critical hydrodynamic shear (Maidhof et al., 2010). In the present 
study, significant improvements of the differentiation process, and of the contractility on 
the cardiac patch, critically depended on the use on a perfusion-based bioreactor culture 
system, as culturing without perfusion could not rescue cardiac contractility.  
Initially, focus was given on the cell density. In fact, it has been demonstrated as the 
seeding step is especially critical to the homogeneity of the construct but also to the 
efficiency of the production process (Wendt et al., 2003). Within the present experimental 
setup, the number of cells loaded through the bioreactor system was defined by optimizing 
the seeding efficiency and yielding a final amount of adherent cell in a range that has been 
previously reported to prime cell proliferation and extracellular matrix synthesis (Zhou et a., 
2006). Moreover, the cell density used was chosen by improving the differentiation 
process, as with the lower density no signs of fusion were observed. 
Concerning seeding, perfusion of a cell suspension through the pores of collagen 
scaffolds proved to be effective in seeding cells at high densities, an important factor in 
engineering tissues that mimic the physiologic cell density, and allow to achieve 
homogeneous spatial distribution throughout the construct volume. We selected a flow 
rate equal to 3 ml/min for seeding based upon a previous study (Maidhof et al., 2010) that 
showed perfusion of a cell suspension through highly porous scaffold could be achieved 
with linear flow rates ranging from 0.6 – 6 ml/min. For culture, medium perfusion at 0.15 
ml/min induced efficient assembly of compacted cardiac tissue, suggesting that our 
selected flow rate was suitable for SM culture. 
Another key requirement is to maximize the cell seeding efficiency and to support 
cell viability achieved by limiting the relatively high flow rate to the initial seeding for only 
24 h period. It has been demonstrated, in fact, that the used seeding technique with (i) 
rapid inoculation of cells into collagen sponges, (ii) immediate establishment of the 
interstitial flow of culture medium through the seeded scaffolds, and (iii) forward-reverse 
flow used for the initial period of 24 h in order to further increase the spatial uniformity of 
cell seeding, is particularly suitable for cardiac TE (Radisic et al., 2003; 2008; Vunjak-
Novakovic and Radisic, 2004). 
On the other hand, the culture medium flow was relatively low in order to 
guarantee enough nutrients and oxygen supplementation for cell survival and 
differentiation without suffering due to high shear stress exposure.  
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The model system used in this study also has some limitations. SM were used as cell source 
because they provide a well characterized and highly controlled proof-of-principle model 
for cardiac TE investigation, and due to the well knowledge (Gianni-Barrera et al., 2013; 
Marsano et al., 2013) and ready availability within the lab. However, for future in vivo tests, 
SMs cannot electrically couple with the resident cardiomyocytes and thus can interfere with 
cardiac conduction and give rise to arrhythmias (Menasché et al., 2008; Gepstein et al., 
2010). 
Our results provide proof-of-principle for generating a thick-relevant cardiac SM-
based contractile 3D patch to be used as functional substitutes or as biological in vitro 
research model systems. The present study demonstrated that perfusion can markedly and 
significantly improve the viability, the contractility, and the uniformity of the engineered 
tissue, allowing cells to express differentiated phenotype. Future work is expected to be 
driven by the need to create thick-relevant grafts with homogeneous tissue architectures 
for controlled in vitro and in vivo studies. In particular, there is a need to co-culture the SMs 
with a vasculogenic cell source in order to obtain a spatially uniform prevascular network, 
to compartmentalize nutrient supply and waste removal in a more physiological way, and 
to enhance cell survival during in vitro cultivation and in vivo implantation. As possible 
strategy, mesenchymal progenitor cells from adipose tissue do not cause arrhythmias 
(Sanchez et al., 2010), are currently undergoing clinical evaluation for the treatment of 
cardiac ischemia (Perin et al., 2010; Houtgraaf et al., 2012), and we could take advantages 
from the knowledge of the group about this type of cells (Scherberich et al., 2010; Güven et 
al., 2011). Moreover, in the next future, the same experiments with a more suitable cell line 
for cardiac TE, as human cardiac progenitor cells derived by heart auricles biopsies, will be 
investigated. 
 
5. Conclusions 
 
We report a new approach of cardiac TE to generate reproducible thick-relevant SM-based 
contractile 3D patches, that is based on the combination of a perfusion-based bioreactor 
culture system and type I collagen scaffold. After culture in a perfusion-based bioreactor 
using three different cell culture medium, SM differentiation was induced with a 
homogeneous distribution within the entire volume of the scaffold, leading to survival of 
the seeded SMs and significant improvement of cardiac contractility. This study confirmed 
the critical roles of perfusion stimulation, cell density, and medium composition for the 
formation of engineered cardiac tissue to be used as functional substitute or as biological in 
vitro research model system.  
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1. Summary and conclusions 
 
It is evident that there are increasing efforts in developing in vitro strategies and methods 
for assessing fundamental myocardial biology and physiology. In addition, recently, there is 
an increasing interest in generation of engineered cardiac constructs in vitro to repair 
damaged tissues in vivo. Therefore, finding innovative approaches for developing 
engineered cardiac constructs will be a major focus of future work in cardiac tissue 
engineering (TE). Thus, future studies will address the issue of how to design cell-scaffold-
bioreactor systems to be used as three-dimensional (3D) model systems for investigating 
the developmental aspects of tissue maturation, and the influence of different biophysical 
stimuli and mass transport on tissue formation, structure, and function. 
In this framework, the works presented in this thesis demonstrate that a 
comprehensive approach, combining complementary aspects of cardiac TE as bioreactor-
based technologies and biological strategies, could provide innovative support tools that 
will be of practical use in the near future, as improved experimental models, and as model 
systems for cardiac development, representing, in the late future, an effective therapeutic 
strategy to the reestablishment of the structure and function of injured cardiac tissues in 
the clinical practice. 
 
The objectives of this thesis, based on engineering and biological approaches in the field of 
cardiac TE, can be summarized as follow: 
 
1) development of two dedicated bioreactors for cardiac TE, and in detail 
- optimization and implementation of a bioreactor for culturing cell-seeded cardiac 
patches, designed for generating a physiological biochemical and physical 
environment that mimics the native stimuli of the cardiac tissue, by providing 
uniaxial cyclic stretching and electrical stimulations; 
- design of an innovative and low-cost suspension bioreactor that, due to its peculiar 
geometric features, allows the formation of buoyant vortices that guarantee the 
establishment of suspension and low-shear cell culture conditions within the culture 
chamber, without using electromechanical rotating systems;  
2) engineering of reproducible thick-relevant skeletal myoblast (SM)-based contractile 3D 
patches by using perfusion-based bioreactor culture system and type I collagen scaffold. 
  
The combination of bioreactor culture systems dedicated to cardiac TE and biological 
cardiac substitutes, that mimic the cardiac natural extracellular matrix (ECM), could 
represent an effective model system for investigating the still unknown mechanisms of 
cardiac development and for drug screening based on the effects of pharmacological 
compounds on biological tissues, and a physiological model of human disease processes 
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that might be prevented or treated if better understood. Moreover, in the late future, such 
approach could represent an effective therapeutic strategy to the reestablishment of the 
structure and function of injured cardiac tissues in the clinical practice. 
 
The principal contributions from each chapter of this thesis are summarized below. 
 
Chapter I – Introduction 
 
The introductory chapter provides a general overview of the anatomy and pathologies of 
the human heart, and a literature review of the cardiac TE background that was necessary 
to understand and guide the work of this thesis. 
 
Chapter II – An electro-mechanical bioreactor providing physiological-like cardiac stimuli. 
 
With the intent to overcome the limitations of the current available bioreactor systems for 
providing physiological-like cardiac stimuli, as the inability to delivery mechanical and 
electrical stimuli at the same time, and to satisfy the good laboratory practice (GLP) rules, in 
this chapter we have presented the optimization and the implementation of a previously 
developed electro-mechanical bioreactor for culturing cell-seeded cardiac patches, 
designed for generating a physiological biochemical and physical environment that mimics 
the native stimuli of the cardiac tissue, by providing uniaxial cyclic stretching and electrical 
stimulations. Our results demonstrated as the bioreactor optimizations performed, allowed 
to obtain a multipurpose adaptable system for dynamic culture of cell-seeded scaffolds, 
that can be used as a model system for 1) testing cytocompatibility and durability of seeded 
patches, and 2) investigating the influence of electro-mechanical stimulation on cells 
cultured on patches. Preliminary findings suggest that in the next future this bioreactor 
could also be used as a production system for implantable functional engineered 
constructs. 
 
Chapter III – An innovative suspension bioreactor. 
  
Suspension culture methods are the most popular means for preventing problems related 
to the two-dimensional (2D) cell culture conditions, by providing a suitable biochemical and 
hydrodynamic 3D environment in the effort to replicate the physical and structural 
components of the native-like microenvironments. In this chapter we have provided an 
alternative solution for recreating suspension conditions, developing an innovative and low-
cost bioreactor that, due to the peculiar geometric features, assures the generation of 
buoyant vortices and the consequent establishment of suspension conditions without using 
electromechanical rotating systems. This behavior allows the creation of a biochemical and 
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hydrodynamic environment suitable 1) to maintain specimens of different dimensions in 
suspension conditions, 2) to guarantee suitable oxygen and nutrient transport , and 3) to 
avoid critical shear stress values affecting the cells by guaranteeing laminar flow conditions. 
Our findings demonstrated as the bioreactor developed presents the potentiality to be 
used as a model system 1) for testing cell/cell-microsphere constructs cytocompatibility and 
durability, and 2) for investigating the influence of suspension condition on cells cultured 
with or without microspheres. Preliminary findings suggest that in the next future this 
bioreactor could also be used as an expansion, aggregation and differentiation system for 
in vitro cell culture. 
 
Chapter IV – Generation of contractile 3D muscle-like tissue in a perfusion-based bioreactor 
culture system. 
 
Cardiac TE has shown the potential to generate thick-contractile myocardium-like 
constructs that might be used as functional substitutes or as biological in vitro model 
systems to investigate the cardiac tissue-specific development and diseases, and to offer 
accurate and controlled in vitro tests for cell and cardiac tissue-based therapies, drug 
screening, predictive toxicology and target validation. Within this scenario, with the aim to 
provide an innovative biological in vitro model system for cardiac TE investigations, we have 
engineered reproducible thick-relevant SM-based contractile 3D patches by using perfusion-
based bioreactor culture system and type I collagen scaffold. Our results provided proof-of-
principle for generating a thick-relevant cardiac SM-based contractile 3D patch, 
demonstrating that perfusion can markedly and significantly improve the viability, the 
contractility, and the uniformity of the engineered tissue, allowing cells to express 
differentiated phenotype. 
 
2. Limitations 
 
Notwithstanding their consistency, the approaches developed within this thesis present 
some limitations: 
 
1) Lack of a real-time monitoring and control system. In works presented in Chapter II and III, 
one of the major important limitations of the bioreactors developed is the lack of a real-
time monitoring system of both culture operating conditions and construct development.  
In this context, besides monitoring the milieu parameters (e.g.: temperature, 
pressure, flow rate, pH, dissolved oxygen and carbon dioxide, metabolite/catabolite 
concentrations, sterility, etc.), monitoring function and structure (e.g.: stiffness, force, 
strength, permeability, composition of the scaffold, cell number, cell viability, etc.) of 
developing engineered cardiac constructs, and design minimally invasive yet reliable 
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monitoring techniques still remain relatively unexplored areas and a highly challenging 
fields of research (Wendt et al., 2009). To date, many real-time monitoring methods are 
available for bioreactors, including conventional electrochemical sensors, and non-invasive 
spectroscopic and optical technologies (Beutel and Henkel, 2011; Teixeira et al., 2011). 
Integration of real-time monitoring technologies should minimize the amount of sample 
extracted for analysis and any disruption to the cell culture itself. Alternatively in-situ 
probes may be incorporated into the bioreactor and this is one of the most favored designs.  
In Chapter II the development of a sensing control block responsible for real-time 
signal acquisition and display without interrupt the cellular experiment is briefly presented. 
At present, only strain signal is available, but this block has been designed to be modular 
and ready to be used for pH, temperature, partial pressure of oxygen signal acquisition and 
display. The user-friendly software for both control and acquisition will allow the user to 
easily perform three types of control over the bioreactor: 1) mechanical stimulation only, 2) 
real-time sensing only and 3) mechanical stimulation and real-time sensing. This findings is 
in line with the current literature studies, in fact, although contractile function is one of the 
most important outputs of engineered cardiac tissues, only a few existing platforms are 
equipped with systems for quantitative force measurement. Some authors transfer the 
generated tissue from a cultivation vessel to a measurement device or organ bath chamber 
(Eschenhagen et al., 1997; 2002; Fink et al., 2000; Zimmermann et al., 2000; 2002; 2006; 
Radisc et al., 2003). A possible weakness of such approach is that force measurement is 
predominantly used as an end-point analysis, and several samples are needed for long-term 
data acquisitions, entailing a huge amount of cells needed, more than that for continuous 
analyses. Recently developed miniaturized platforms attempt to bridge this gap by allowing 
direct (using specific force sensors (Kensah et al., 2011)) or indirect (using optical analysis 
(Hansen et al., 2010; Boudou et al., 2012)) measurement of the contraction forces, providing 
noninvasive online monitoring during prolonged culture.  
In Chapter III the possibility to implement specific sensors and control system for 
the on-line, high throughput monitoring of basic parameters such as temperature, pH, 
partial pressure of oxygen and carbon dioxide is under investigation. These functioning 
modalities will be suitable for a lot of experiments aimed at investigated the environment 
within the culture chamber, providing the user with several quantitative data to be used to 
implement a control system of the experimental parameters.  
 
2) Cell source. In work presented in Chapter IV one of the major important limitations of the 
engineered cardiac patch developed concerns the choice of an unsuitable cell source for 
cardiac TE. 
SMs are widely use in cardiac TE thanks to their high proliferative potential, high 
resistance to ischemia, and their fate restriction to the myogenic lineage, with the capacity 
to develop a complete contractile apparatus, virtually eliminates the risk of tumorigenicity 
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(Menasché, 2004; 2008). On the other hand, the major disadvantage of SMs is that they do 
not electrically couple with the host cardiomyocytes (Durrani et al., 2010), and this 
obviously raises the major question of the mechanisms by which, in case of cell 
transplantation, the myoblasts can improve left ventricular function (Manasché, 2004). 
Despite this concern, within this work, SMs were used as cell source because they 
provide a well characterized and highly controlled proof-of-principle model for cardiac TE 
investigation, and due to the well knowledge (Gianni-Barrera et al., 2013; Marsano et al., 
2013) and ready availability within the lab.  
 
3. Recommendations for future works 
 
For overcoming the above mentioned limitations, in the future further in-depth strategies 
could be developed in order to: 
1) integrate real-time monitoring technologies for minimizing the amount of sample 
extracted for analysis and any disruption to the cell culture itself, by incorporating in-situ 
probe, conventional electrochemical sensors, and non-invasive spectroscopic and optical 
technologies; 
2) simplify the process for minimizing the operator dependent variability, the labor costs, 
and the time and effort needed in order to perform experiments, by reducing the number 
of the bioreactor variables/components, therefore making easier the use of the systems 
also by non-experienced staff; 
3) perform experiments in a condition much closer to the native-like environment, by 
changing the cell source with a more suitable cell line for cardiac TE, as human cardiac 
progenitor cells derived by heart auricles biopsies. 
Moreover, a further study could concern the creation of thick-relevant grafts with 
homogeneous tissue architectures for controlled in vitro and studies. In particular, there is a 
need to co-culture the cardiac cells with a vasculogenic cell source in order to obtain a 
spatially uniform prevascular network, to compartmentalize nutrient supply and waste 
removal in a more physiological way, and to enhance cell survival during in vitro cultivation 
and in vivo implantation. As possible strategy, cell-based angiogenic approaches focused on 
the use of not genetically modified mesenchymal stem cells (MSC) of different origins, are 
becoming promising strategy for supporting the regeneration of injured cardiac tissues 
(Melly et al., 2012). Specifically, adipose tissue-derived stromal vascular fraction (SVF) are 
currently undergoing clinical evaluation for the treatment of cardiac ischemia (Perin et al., 
2010; Houtgraaf et al., 2012), and contain a heterogeneous cell population, which makes SVF 
cells capable of both in vitro and in vivo vasculogenesis. 
Furthermore, due to the importance that the topic is having in the last decade 
within the scientific community, a further line of research could consists in the exploration 
of the role of bioreactors in the stem cell (SC) culture. Currently, in fact, the large majority 
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of SC products undergoing translation into the clinic, particularly those to be used in 
regenerative medicine settings, rely on traditional static culture systems to achieve 
required cell doses. However, the successful implementation of SC therapies requires the 
large-scale production of SC products, regulated by industrial manufacturing standards with 
proven reproducibility and process quality control. The recent advances in the development 
of bioreactor systems for the expansion of SC and/or their controlled differentiation have 
now taken this technology to the point where clinical-scale productivities can be achieved. 
In addition, the success of clinical trials involving SC and the necessary approval of these 
therapies by regulatory agencies will demand more advanced and cost-effective 
manufacturing tools. The translation of bioreactor systems, with integrated and customized 
downstream processing, to good manufacturing practice (GMP) conditions will be very 
important for the large-scale production of SC therapies. In addition, although most clinical 
trials are currently being or will be run using SC produced using classic, static culture 
systems, these systems can later be replaced by bioreactor systems when required for 
market-scale production, if such systems are approved by regulatory agencies through drug 
comparability studies (e.g. to assure product identity, therapeutic potency and safety). It 
will then be critical to continue the development of bioreactors for SC expansion, under 
GMP-guided research, to overcome the expected technological barriers that will likely be 
encountered when these therapies reach the market stage (dos Santos et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter V – Conclusions and Future Works  
187 
 
References 
Beutel S, Henkel S. In situ sensor techniques in modern bioprocess monitoring. Applied 
Microbiology and Biotechnology, 2011, 91(6):1493-505.  
 
Boudou T, Legant WR, Mu A, Borochin MA, Thavandiran N, Radisic M, Zandstra PW, Epstein 
JA, Margulies KB, Chen CS. A microfabricated platform to measure and manipulate the 
mechanics of engineered cardiac microtissues. Tissue Engineering Part A, 2012, 18(9–
10):910–919. 
 
dos Santos FF, Andrade PZ, da Silva CL, Cabral JM. Bioreactor design for clinical-grade 
expansion of stem cells. Biotechnology Journal, 2013, 8(6):644-54.  
 
Durrani S, Konoplyannikov M, Ashraf M, Haider KH. Skeletal myoblasts for cardiac repair. 
Regenerative Medicine, 2010, 5(6):919-32. 
 
Eschenhagen T, Fink C, Remmers U, Schols H, Wattchow J, Weil J, Zimmermann W, Dohmen 
HH, Schäfer H, Bishopric N, Wakatsuki T, Elson EL. Three dimensional reconstitution of 
embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. 
Federation of American Societies for Experimental Biology Journal, 1997, 11:683–694. 
 
Eschenhagen T, Didié M, Heubach J, Ravens U, Zimmerman WH. Cardiac tissue engineering. 
Transplant Immunology, 2002, 9(2–4):315–321. 
 
Fink C, Ergün S, Kralisch D, Remmers U, Weil J, Eschenhagen T. Chronic stretch of 
engineered heart tissue induces hypertrophy and functional improvement. Federation of 
American Societies for Experimental Biology Journal, 2000, 14(5):669–679. 
 
Gianni-Barrera R, Trani M, Fontanellaz C, Heberer M, Djonov V, Hlushchuk R, Banfi A. VEGF 
over-expression in skeletal muscle induces angiogenesis by intussusception rather than 
sprouting. Angiogenesis, 2013, 16(1):123-36.  
 
Hansen A, Eder A, Bönstrup M, Flato M, Mewe M, Schaaf S, Aksehirlioglu B, Schwörer A, 
Uebeler J, Eschenhagen T. Development of a Drug Screening Platform Based on Engineered 
Heart Tissue. Circulation Research, 2010, 107:35–44. 
 
Houtgraaf JH, den Dekker WK, van Dalen BM, Springeling T, de Jong R, van Geuns RJ, 
Geleijnse ML, Fernandez-Aviles F, Zijlsta F, Serruys PW, Duckers HJ. First experience in 
humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-
Chapter V – Conclusions and Future Works  
188 
 
segment elevation myocardial infarction. Journal of the American College of Cardiology, 
2012, 59(5):539-40. 
 
Kensah G, Gruh I, Viering J, Schumann H, Dahlmann J, Meyer H, Skvorc D, Bär A, Akhyari P, 
Heisterkamp A, Haverich A, Martin U. A novel miniaturized multimodal bioreactor for 
continuous in situ assessment of bioartificial cardiac tissue during stimulation and 
maturation. Tissue Engineering Part C Methods, 2011, 17(4):463–473. 
 
Marsano A, Maidhof R, Luo J, Fujikara K, Konofagou EE, Banfi A, Vunjak-Novakovic G. The 
effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on 
vascularization in a mouse model of myocardial infarction. Biomaterials, 2013, 34(2):393-401.  
 
Melly L, Boccardo S, Eckstein F, Banfi A, Marsano A. Cell and Gene Therapy Approaches for 
Cardiac Vascularization. Cells, 2012, 1(4):961-975. 
 
Menasché P. Skeletal myoblast transplantation for cardiac repair. Expert Review of 
Cardiovascular Therapy, 2004, 2(1):21-8. 
 
Menasché P. Skeletal myoblasts and cardiac repair. Journal of Molecular and Cellular 
Cardiology, 2008, 45(4):545-53.  
 
Perin EC, Sanchez PL, Ruiz RS, Perez-Cano R, Lasso J, Alonso-Farto JC, Fernandez-Pina L, 
Serruys PW, Duckers HJ (Eric), Kastrup J, Chameleau S, Zheng Y, Silva GV, Milstein AM, 
Martin MT, Willerson JT, Aviles FF. First in man transendocardial injection of autologous 
AdiPose-deRived StEm cells in patients with non RevaScularizable IschEmic myocardium 
(PRECISE). Circulation, 2010, 122. 
 
Radisic M, Euloth M, Yang L, Langer R, Freed LE, Vunjak-Novakovic G. High-density seeding 
of myocyte cells for cardiac tissue engineering. Biotechnology and Bioengineering, 2003, 
82(4):403–414. 
 
Teixeira AP, Duarte TM, Carrondo MJ, Alves PM. Synchronous fluorescence spectroscopy as 
a novel tool to enable PAT applications in bioprocesses. Biotechnology and Bioengineering, 
2011, 108(8):1852-61.  
 
Wendt D, Riboldi SA, Cioffi M, Martin I. Potential and bottlenecks of bioreactors in 3D cell 
culture and tissue manufacturing. Advanced Materials, 2009, 21(32–33):3352–3367. 
 
Chapter V – Conclusions and Future Works  
189 
 
Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T. Three-dimensional 
engineered heart tissue from neonatal rat cardiac myocytes. Biotechnology and 
Bioengineering, 2000, 68(1):106–114. 
 
Zimmermann WH, Didié M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, Boy O, 
Neuhuber WL, Weyand M, Eschenhagen T. Cardiac grafting of engineered heart tissue in 
syngenic rats. Circulation, 2002, 106(12 Suppl 1):151–157. 
 
Zimmermann WH, Melnychenko I, Wasmeier G, Didié M, Naito H, Nixdorff U, Hess A, 
Budinsky L, Brune K, Michaelis B, Dhein S, Schwoerer A, Ehmke H, Eschenhagen T. 
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. 
Nature Medicine, 2006, 12(4):452–458. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter V – Conclusions and Future Works  
190 
 
 
 
 
 
 
 
